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A. Summary 
 
Interleukin (IL)-7 is a cytokine, which is crucial for the development of the murine 
immune system. It is required for lymphopoiesis and for the development of peripheral lymph 
nodes (LN). IL-7-/-mice have impaired B and T cell lymphopoiesis, decreased numbers of 
peripheral B and T cells and are devoid of γδ T cells. IL-7 signals through a receptor composed 
of the common γ (γc) and the IL-7Rα chain. The latter chain can also pair with the γc-like chain 
called thymic stromal lymphopoietin receptor (TSLPR). Both form the receptor of the cytokine 
called thymic stromal lymphopoietin (TSLP). . 
Originally identified for its capacity to promote B cell development in vitro, TSLP was 
later shown to induce dendritic cell maturation, to trigger allergic diseases and to drive TH2 
differentiation. Several evidences suggested that TSLP might play a role in fetal B 
lymphopoiesis and that fetal but not adult cells were TSLP-responsive. However, the function of 
TSLP in hematopoiesis and in LN organogenesis in vivo remained elusive. In the work presented 
in the first part of this thesis, I have characterized the function of TSLP in adult lymphopoiesis. 
This study shows that TSLP transgene (Tg) expression restored all developing B cell 
compartments in the bone marrow (BM), DN1 and DN2 thymocytes and thymic architecture, 
and all peripheral B and αβ and γδ T cell compartments in IL-7-/- mice. The expression of the 
TSLP Tg increased thymic and splenic cellularities. The analysis of the junctions of the 
immunoglobulin heavy chain locus showed that the DNA of B cells from IL-7-/- TSLP Tg mice 
contained N nucleotides, suggesting that adult hematopoietic progenitors are TSLP-responsive. 
Moreover, BM chimera experiments showed that WT BM precursors differentiated towards B- 
and T-cell lineages in response to TSLP, further suggesting that adult hematopoietic cells are 
TSLP-responsive. In this line, we show that TSLP had the capacity to promote the proliferation 
and the differentiation of DN1 and DN2 thymocytes as well as the differentiation of 
uncommitted adult BM precursors towards the B and the T cell lineage in vitro. Hence, these 
results altogether showed that TSLP has the capacity to promote long-term adult lymphopoiesis 
in the absence of IL-7. 
Lymph node (LN) development starts during fetal life and crucially relies on the 
interaction between the hematopoietic lymphoid tissue inducer (LTi) cells and the mesenchymal 
organizer cells. Both together cluster in a cellular aggregate called LN anlage. This LN anlage is 
colonized by peripheral lymphocytes after birth, and gives rise to a mature LN organized into B 
cell follicles and a T-cell zone. Mice deficient for IL-7 or for molecules of the IL-7 signaling 
pathway lack several LN but the reasons underlying this defect are still not clear. As IL-7 
regulates the size of the LTi cell pool, a possibility is that LN development in IL-7-/- mice is 
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impaired because of insufficient LTi cell number. Alternatively, it was proposed that the lack of 
colonization of the LN anlage by peripheral lymphocytes might prevent the maintenance of the 
LN anlage. I show in the second part of this thesis, that TSLP overexpression increased LTi cell 
number and restored LN development in IL-7-/- and RAG2-/- γc-/- mice, suggesting that LTi cell 
number is a critical parameter for LN organogenesis. The LN anlage of RAG2-/- γc-/- TSLP Tg 
mice were devoid of peripheral lymphocytes, ruling out that lymphocytes are required for LN 
maintenance. Thus, the results shown here define organizer and LTi cells as the minimal cellular 
requirement for LN development and suggest that the lack of LN in mice lacking molecules of 
the IL-7 pathway is the result of suboptimal LTi cell number. This study further shows that 
lymphocyte colonization is required for establishing a correct LN architecture and for the 
differentiation of some mesenchymal populations within the LN microenvironment. 
Overall, this study shows that TSLP can substitute IL-7 for murine lymphopoiesis and for 
LN organogenesis and suggest that the impaired lymphopoiesis and LN organogenesis in IL-7-/- 
mice is the consequence of limited availability of endogenous TSLP. 
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B. Introduction 
 
1. Lymphopoiesis 
 
1.1 Introduction 
Hematopoietic stem cells (HSCs) are defined by their ability to self-renew and to 
differentiate towards all blood cell lineages. The generation of B and T lymphocytes relies on the 
continuous differentiation of progenitors derived from HSC within the bone marrow (BM) and 
the thymic microenvironments, respectively. Both B and T lymphopoiesis are regulated by a 
number of differentiation, survival and growth factors that are provided by the resident stromal 
cells. The factors and cells supporting hematopoiesis constitute what is defined as the “niche”. 
Here are described the major cellular and molecular events taking place during lymphopoiesis in 
primary lymphoid organs. A particular emphasis is placed on the factors, which contribute to 
hematopoietic niches and which are required for generation, maturation and survival of 
developing and mature lymphocytes. 
 
1.2 B cell development  
During fetal life, B cell development occurs in the liver while it is restricted to the BM at 
adulthood. B cells develop according a similar general program in fetal liver (FL) and adult BM, 
except that fetal B cells do not express the terminal deoxynucleotidyl-transferase (Tdt) [1], 
which is required for incorporating N nucleotides during heavy chain (HC) rearrangement [2]. 
Cytokines are amongst the most important factors for B cell development in vitro and in vivo. 
For instance, stem cell factor (SCF) and fms-related tyrosine kinase 3 Ligand (Flt3L) play a 
central role in adult B lymphopoiesis. Mice deficient for the SCF receptor c-Kit [3] and for Flt3L 
[4] have an early block in B cell development. Similarly, interleukin (IL)-7 is required for adult 
B lymphopoiesis in vivo [5-7]. While adult B cell development crucially relies on IL-7, it seems 
that fetal and perinatal B lymphopoiesis is less stringently dependent on IL-7. Thus, the BM of 
newborn IL-7-/- mice contains substantial numbers of CD19+ B cells, which gradually disappear 
with age [5]. 
The first subset of committed B cells is defined as CD19+ CD117+ fraction (Figure 1). It 
contains pro-B cells having Ig genes in germline configuration and pre-B-I cells with rearranged 
DHJH loci [8]. Pro-B/pre-B-I cells express IL-7Rα [9], proliferate in response to IL-7 in vitro 
[10] and accumulate in the BM of IL-7 Tg animals [11]. In line with these results, IL-7-/- and IL-
7Rα-/- adult mice lack pro-B/pre-B-I cells in the BM [5-7]. 
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Pro-B/pre-B-I cells develop into large pre-B-II cells, which are CD19+ CD117- CD25+ [12] 
and have rearranged at least one VHDHJH allele [8]. Productive VHDHJH rearrangement and 
pairing with the surrogate light chain coded by the VpreB and λ5 genes, are both required for 
successful pre-BCR expression. Pre-BCR signals are required for the downregulation of the 
recombination activating genes (Rag) and Tdt genes [13]. Importantly, assembly of complete 
pre-BCR is crucial for the expansion of pre-B-II cells while allelic exclusion depends on the 
presence of µHC but not of the surrogate light chain components [14-17]. Consistently with the 
fact that large pre-B-II cells express IL-7Rα [9], the size of the CD19+ CD25+ Pre-B-II 
compartment is increased in IL-7 Tg mice compared to WT animals [11]. After 5-7 divisions, 
large Pre-B-II cells go back to a resting state.  
The subsequent small CD19+ CD25+ pre-B-II cells start to rearrange the light chain (LC) 
loci with a strong bias for the κ locus compared to the λ locus [8]. The cells that have 
productively rearranged the LC locus and that express Ig at their surface are called immature B 
cells and appear as CD19+ CD25- IgMhigh. Immature B cells do not express IL-7Rα and do not 
respond to IL-7. Hence, the crucial role fulfilled by IL-7 for B lymphopoiesis seems to be in 
sustaining the generation and expansion of early B cell progenitors from pro-B to large pre-B-II.  
Immature B cells undergo selection processes within the BM microenvironment in order to 
remove auto-reactive B cells from the repertoire. Hence, immature B cells recognizing self-Ag 
with high affinity are either eliminated (clonal deletion) [18], become anergic, or are given the 
chance to change specificity by rearranging the LC locus [19, 20], a phenomenon known as 
receptor editing [21]. 
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1.3 Peripheral B cells 
Immature B cells leave the BM, enter the blood stream and reach the spleen. The newly 
entered immature B cells are easily detectable in the spleen as they still express CD93. They can 
be separated into transitional 1 (T1) and transitional 2 (T2) cells. T1 cells are IgMhigh IgDlow 
CD21- CD23- while T2 B cells are IgMhigh IgD+ CD21+ CD23+. T1 and T2 B cells are 
characterized by their propensity to undergo apoptosis upon BCR engagement, rather than to 
proliferate [22, 23]. B cell maturation is thought to occur in a process during which T1 and T2 B 
cells give rise to CD93- mature splenic B cells, along pathways that are still debated. Mature 
splenic B cells can be subdivided into CD21high CD23- marginal zone (MZ) B cells and CD21+ 
CD23+ follicular B (FB) cells [24].  
In mice, MZ B cells represent 5% of splenic B cells and are sessile cells located in the 
vicinity of the marginal sinuses of the spleen [25]. MZ B cell generation crucially depends on 
Notch2 signals, as deletion of the Notch2 gene in hematopoietic cells specifically prevents the 
development of MZ B cells [26]. MZ B cells have a limited BCR repertoire and mount mainly T-
independent Ab responses against blood-borne viral and bacterial pathogens [25]. MZ B cells 
differentiate into Ab-secreting cells upon BCR ligation or toll-like receptor (TLR) activation.  
FB cells represent the main splenic B cell population and are the cells mounting T-cell 
dependent Ab responses against protein Ags [27]. Upon concomitant BCR activation and 
ligation of CD40 by activated T cells, FB cells undergo somatic hypermutation, class switching 
recombination, and differentiation towards long-lived Ab-secreting plasma cells. FB cells are 
circulating cells that are found in the spleen, LN, the blood and the BM [27]. Interestingly, 
increased IL-7 availability promotes the expansion of the FB but not of the MZ compartment 
[28]. 
Recently, a crucial factor for peripheral B cell compartments called B-cell activating factor 
belonging to the TNF family (BAFF) was discovered. BAFF is a survival and maturation factor 
for T2, mature B and for autoreactive B cells in the spleen. BAFF-/- mice have a block at the T1 
stage, and lack T2, MZ and follicular B cells [29]. Conversely, BAFF overexpression leads to B 
cell hyperplasia and to autoimmune disease [30] through the rescue of self reactive B cells from 
deletion [31]. These results indicate that both the deletion of auto-reactive B cells and the size of 
peripheral B cell compartments are dependent on BAFF availability.  
B-1 B cells are peripheral B cells which are mainly found in the peritoneal cavity and are 
phenotypically defined as CD19+ B220low IgMhigh IgDlow. B-1 B cells contribute to T-
independent responses against bacterial Ag such as phosphorylcholine [27]. B-1 B cells can be 
separated according expression levels of CD5 into CD5+ B-1a and CD5- B-1b B cells. B-1 B 
cells develop normally in IL-7-/- [5] and BAFF-/- [29] mice, suggesting that this subset requires 
different factors for generation and/or homeostasis. 
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1.4 T cell development 
The thymus is continuously seeded by BM precursors, which have entered the blood 
circulation. These progenitors enter the thymus at the corticomedullary junction. While the 
phenotype of the early thymic immigrants is still unclear, the identification of subsequent 
populations is well established. T lymphopoiesis occurs in a stepwise process during which early 
T cell progenitors cells sequentially rearrange the loci of the T cell receptor (TCR) genes. The 
cells, which have productively recombined tcr genes will later undergo positive and negative 
selection.  
Adult T lymphopoiesis relies on the crucial IL-7 and Notch1 signals. IL-7-/- and IL-7Rα-/- 
mice have severely decreased thymocytes numbers [6, 7] and an early block in thymopoiesis 
[32]. Hematopoietic cells deficient for Notch1 fail to differentiate towards T cells in vivo [33] 
and T cell development in vitro can be achieved only in the presence of Notch ligands [34].  
The first T cell progenitors are called double negative (DN), as they express neither CD4 
nor CD8 (Figure 2). DN thymocytes can be further separated into 4 subsets according their levels 
of expression of CD25, CD44 and CD117 [9]. DN1 have TCR genes in germline configuration 
and appear as CD117high CD44+ CD25- cells [9]. These cells differentiate to DN2 cells, which 
have rearranged the Dβ-Jβ locus and are CD117high CD44+ CD25+. Both DN1 and DN2 
thymocytes are absent in IL-7-/- mice [32] and both proliferate in response to IL-7 and Notch 
signals [35]. In turn, DN2 develop into DN3 cells that are CD117+ CD44- CD25+ and have 
rearranged the Vβ-DJβ locus. In the adult, Notch but not IL-7 signals are required for DN3 
proliferation [35]. Most TCRβ rearrangements in the DN3 cells are non-productive while those 
in the subsequent DN4 cells are mainly in frame [36]. This illustrates a process named β-
selection, where only DN3 thymocytes which have productively rearranged the TCRβ locus and 
that can express the pre-TCR at their surface will differentiate towards the CD117- CD44- CD25- 
DN4 stage. Notch1 signals are required to make the Vβ-DJβ recombination [37] and for 
expression of the pre-Tα [38]. IL-7 and Notch signals, which are crucial for DN1, DN2 and DN3 
thymocytes, are provided by Keratin (K)8+ K5- cortical thymic epithelial cells (TEC) [39]. 
DN4 cells differentiate into CD4+CD8+ double positive (DP) thymocytes, which have 
productively rearranged the TCRα locus. DP cells express a unique TCR at their surface and 
interact with peptide-MHC complexes presented by cortical TECs [39]. Low avidity interactions 
will induce DP thymocytes to survive [40], a phenomenon referred as positive selection. On the 
contrary, DP thymocytes that recognize self peptide-MHC complexes with high affinity will 
undergo apoptosis. This process, known as negative selection, ensures the deletion of self-
reactive T cells from the repertoire [41]. Thymocytes, which have a very low avidity for self 
peptide-MHC complexes will die by neglect. Positively selected DP thymocytes differentiate 
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towards CD4+ or CD8+ single positive (SP) cells and migrate from the cortex to the medulla. SP 
thymocytes undergo another round of negative selection performed by DC and K8- K5+ 
medullary TEC. As many of these stromal cells express tissue-specific Ag in a promiscuous 
fashion, they further purge the T cells that recognize tissue-specific self-Ags from the repertoire. 
The thymic medulla is also the place where regulatory T cells (Treg) are generated, which can 
suppress T-mediated immune responses and are required for tolerance to self-Ag. Overall, only 
1-3% of thymocytes successfully differentiated and are exported from the thymus [39]. 
 
 
 
 
 
1.5          γδ T cells 
γδ T cells are unconventional T cells, which have the capacity to recognize classical 
and non-classical MHC Ag. γδ T cells develop in the thymus along schemes that are still 
under debate. They are generated along sequential waves during ontogeny. For example, 
Vγ3+, Vγ4+ and Vδ1+ cells are produced during fetal life, while Vγ1+ and Vδ4+ develop 
during adulthood [42]. γδ T cells represent one of the most prominent hematopoietic 
population within epithelial tissues such as skin, lung and intestinal epithelium [42]. Many 
γδ T cells have a highly restricted TCR diversity: hence, the skin is mainly populated by 
Vγ3+ T cells [43] and the intestinal epithelium harbors mostly Vγ5+ cells [42]. While their 
role is not firmly established, γδ T cells might be involved in cellular immunity, tumor 
surveillance, and epithelial immunoregulation [44].  
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1.6 Peripheral T cells  
Peripheral T cells are mainly composed of CD4+ or CD8+ cells expressing αβ TCR. Both 
CD4 and CD8 compartments can be further divided into CD44low naïve T cells and CD44high 
memory T cells [45]. Naïve T cells express also L-selectin (CD62L) which allow them to enter 
LN via specialized blood vessels called high endothelial venules (HEV). Naïve T cells are 
almost exclusively found in secondary lymphoid organs. Memory cells are the progeny of T cells 
that have encountered Ag. The pool of memory cells is composed of CD62L- T cells, which 
patrol peripheral tissues and of CD62L+ memory T cells, which home to spleen and LN.  
The survival and homeostasis of naïve and memory T cells are controlled by IL-7 [46]. IL-
7-/- and IL-7Rα-/- mice have decreased number of peripheral T cells [6, 7]. Other γc-dependent 
cytokines, such as IL-15 but also interactions with self-Ag/MHC are factors controlling the size 
and the homeostasis of peripheral T cell compartments [45]. 
 
2. Lymph node organogenesis 
 
2.1 Introduction 
Lymph nodes (LN) are highly organized organs, which collect Ag drained from all tissues. 
They provide specialized microenvironments where adaptive immune responses are mounted. 
Since adaptive immune responses rely on the activation and expansion of rare Ag-specific cells, 
LN represent the evolutive solution for maximizing cellular interactions and for mounting rapid 
Ag-specific response [47]. In agreement with this view, absence of LN prevents the 
establishment of protective anti-viral response [48]. Besides, LN provide microenvironments 
where peripheral T cell tolerance takes place [49] and might play a substantial role in 
lymphocyte homeostasis by producing growth and survival factors [50]. 
 
2.2 LN architecture 
The main cellular components of LN are hematopoietic, mesenchymal and endothelial 
cells, the later two forming the stroma together with extracellular matrix and reticular fibers [47]. 
LN are encapsulated organs composed of cortex and medulla [49] (Figure 3). The medulla 
contains short-lived plasma cells, few memory T cells and macrophages [49]. It is largely packed 
with lymph-draining sinuses and blood vessels [49]. The cortex is composed of B cell follicles 
surrounding the T cell area also named paracortex. B-cell follicles are the sites where humoral 
responses are mounted while the paracortex is the microenvironment where DC and T cells 
interact [49]. Most B and T lymphocytes enter LN via HEVs that are localized in the paracortex. 
T/B compartmentalization is mediated through chemoattractants, which are produced by stromal 
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cells. Hence, B-cell stroma produces CXCL13 [51], which attracts CXCR5+ B cells while T-cell 
stroma releases CCL19 and CCL21, which attract CCR7+ T cells [52].  
Lymph enters the LN via afferent lymphatic vessels in the space below the capsule, called 
the subcapsular sinus. From there, it flows through intermediate sinuses within the LN 
parenchyma towards the medulla, where it eventually exits the LN at the medullary sinus via the 
efferent lymphatic vessel. It was recently found that LN also contain small channels called 
conduits, which transport low molecular weight (MW) particles such as chemokines from the 
subcapsular sinus to the T-cell area and the HEVs [53]. The lymph content is sampled by 
peculiar DC, which are intimately associated with the conduits [54]. High MW compounds (>80 
kD) entering the subcapsular sinus are excluded from the conduits and are directly conducted 
towards the medullary sinus [53]. The conduits and the HEVs are enwrapped by stromal cells 
called fibroblastic reticular cells (FRC). FRCs form a 3-dimensional reticular network within the 
LN [55], which is dynamically remodeled during immune responses [56]. While the FRC 
network assures T cell motility, networks of follicular dendritic cells allow B cell movements 
within the follicle [57]. 
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2.3 Role of the Lymphotoxin pathway for LN organogenesis 
The emergence of mouse embryonic stem cell technologies opened up the possibility to 
generate mice with a specific deletion of a gene of interest. Deletion of genes from the tumor 
necrosis factor (TNF) family shed light on central mechanisms underlying LN organogenesis.  
The TNF family includes 4 members [58]: TNF, lymphotoxin (LT)α, LTβ and LIGHT  
(Figure 4). TNF signals through two receptors TNFR1 and TNFR2 [58]. LTα and LTβ can form 
the membrane-bound heterotrimer LTα1β2 which signals through the receptor LTβR [59]. 
Beside LTα1β2, LIGHT is the sole ligand known to bind LTβR [60]. LTα can form the soluble 
trimer LTα3 that is a ligand for both TNFR1 and TNFR2 [58]. LIGHT and, to a lesser extent, 
LTα3 bind to the receptor HSV entry mediator (HVEM) [60]. 
One of the first hints concerning the molecular mechanisms of LN formation emerged 
from the generation of LTα deficient mice. LTα-/- animals were reported to lack all LN and PP 
[61, 62]. Approaches neutralizing the LT pathway with LTβ-R-Fc chimeric proteins showed that 
LN organogenesis occurred in sequential steps during fetal development [63]. In agreement with 
a central role of the LT pathway in organogenesis, LTβR-/- mice were shown to lack LN and PP 
[64]. However, later studies showed that LTβ-/- mice lacked PP and peripheral LN except 
cervical and mesenteric LN [65, 66], suggesting that LTβR ligands other than LTα1β2 play a 
role in LN organogenesis. In fact, LIGHT-/- LTβ-/- mice develop mesenteric LN in lower 
frequency than LIGHT-/- animals showing that LIGHT contributes to some extent to mesenteric 
LN formation [67]. 
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There is no evidence indicating that TNF participate to LN organogenesis. Hence, animals 
deficient for TNF [68], TNFR1-/- [69], or TNFR2-/- [70] have normal LN development. TNF-/- 
LTβ-/- mice develop mesenteric LN [71], further demonstrating that TNF does not participate in 
mesenteric LN development. However, TNFR1-/- LTβ-/- mice are devoid of mesenteric LN [72], 
indicating that LTα3 and LTα1β2 cooperate in the formation of these LN. 
Overall these results showed that the interaction between LTα1β2 and LTβR is the main 
molecular pathway involved in the development of peripheral LN and that molecules such as 
LTα3 and LIGHT might participate and/or cooperate to the formation of mesenteric LN.  
 
2.4 Lymphoid tissue inducer cells 
Lymphoid tissue inducer (LTi) cells are hematopoietic cells, which were initially described 
as CD4+ CD3- IL-7Rα+ c-kitlow in the spleen, LN and peripheral blood of embryos and newborn 
mice [73]. As these cells expressed high levels of LTα1β2, it was speculated that they might be 
implicated in LN development [73]. Cells with an identical phenotype were reported to cluster in 
fetal gut and participate to Peyer’s patch (PP) development [74-76]. Furthermore, adoptive 
transfer of LTi cells restore PP development in CXCR5-/- newborn mice [77], demonstrating that 
LTi cells have the capacity to induce secondary lymphoid organ development. 
Further information about the crucial role of LTi cells in LN organogenesis came from the 
fact that mice deficient for the transcription factors Id2 [78], Ikaros [79] and RORγ-/- [80], which 
all lacked LTi cells, were completely devoid of LN and PP. In this line, RORγt, a RORγ isoform 
expressed in LTi cells during fetal life, is crucial for LTi cell generation [81]. Altogether, these 
results show that LTi cells are instrumental for LN and PP development. 
 
2.5 Fetal liver progenitors of LTi cells 
Two FL progenitors have been independently identified as putative precursors for LTi 
cells. Sca-1low CD117low IL-7Rα+ FL cells were reported to differentiate towards cells with LTi 
phenotype when injected into newborn mice [82]. Independently, lineage- α4β7+ IL-7Rα+ FL 
cells were described for their capacity to differentiate towards LTi cells in vitro [83]. Of note, 
both populations do not exclusively give rise to LTi cells but have the capacity to differentiate 
towards other hematopoietic lineages. Various approaches revealed that LTi cells are present in 
LN and PP anlagen, in blood and spleen but not in FL [73, 76, 81]. While these results do not 
give definitive answers about the direct LTi precursor(s), they altogether suggest that LTi 
precursors originate from the FL and that they migrate to the periphery where they differentiate 
into LTi cells. 
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2.6 Organizer cells  
Organizer cells are from mesenchymal origin, express the LTβR and were originally 
identified as VCAM-1+ ICAM-1+ cells in the fetal gut [84]. These cells form clusters along the 
intestinal gut and form the PP anlage [75]. PP organizer cells express CXCL13, CCL19 and IL-7 
[84, 85]. Similarly, LN organizer cells were described in mucosal and peripheral LN anlagen as 
VCAM-1+ ICAM-1+ cells [86, 87]. In addition to LTβR, LN organizer cells express the 
cytokines TRANCE and produce IL-7 and the chemokines CXCL13, CCL19 and CCL21 [86, 
88]. Organizer from inguinal and mesenteric LN differ by their levels of expression of adhesion 
molecules [86], suggesting that peripheral and mucosal LN develop from phenotypically distinct 
organizer cells.  
 
2.7 Model for LN development 
LN organogenesis crucially relies on the interaction of LTi cells with organizer stromal 
cells [85, 89]. At 12.5-13.5 days post-coitus (dpc), LTi cells start to cluster at sites of nascent LN 
anlage [87]. LTi cells engage the LTβ receptor present on organizer cells (Figure 5). Organizer 
cells cluster the successive day in a LTα-dependent manner [87]. LTβR engagement leads to the 
upregulation of adhesion molecules such as VCAM-1 and ICAM-1 but also to the production of 
chemokines such as CXCL13, CCL19 and CCL21 [90]. LTi cells, which migrate in vitro in 
response to these chemokines [84], are recruited to the LN anlage, and provide further LT 
signals. This positive feedback loop allows the formation of stable clusters of LTi and organizer 
cells, which will later be colonized by mature lymphocytes. 
 
2.8 Important factors for LN organogenesis 
 
2.8.1 Cytokines 
Several cytokines play a substantial role in LN organogenesis. For instance, IL-7 is 
required for complete LN development as IL-7-/- and IL-7Rα-/- mice lack several peripheral LN 
[91, 92]. The lack of LN is identical in γc-/- mice and IL-7Rα-/- mice [91], suggesting that IL-7 is 
the main γc cytokine for LN formation. The reasons why IL-7-/-, γc-/- and IL-7Rα-/- mice have a 
reduced number of LN remain unclear. IL-7 has two effects on LTi cells. On one side, IL-7 
induces the upregulation of LT expressed by LTi cells in vitro [84, 87, 91] and in vivo [91, 92]. 
On the other side, IL-7 mediates LTi cell survival in vitro and its overexpression leads to the 
increase in LTi cell number in the spleen and mesenteric LN of newborn mice compared to WT 
controls [92]. Indeed, mesenteric LN from IL-7Rα-/- newborn mice contain decreased number of 
LTi cells compared to WT, suggesting that either LTi cell recruitment in the LN anlage is 
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Figure 5. Model for lymph node organogenesis
Adapted from Mebius, Nature Reviews Immunology (2003).
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defective in the absence of IL-7Rα signals or/and that IL-7Rα signals are required for 
maintaining normal LTi cell numbers. Mice double deficient for IL-7Rα and flt3L are devoid of 
LN [93], suggesting that synergism between cytokines might play a role in LN organogenesis. 
Mice deficient for the tumor necrosis factor-related activation induced cytokine 
(TRANCE) also lack all LN [94]. The percentage of LTi cells among CD45+ cells is decreased in 
the LN anlage of TRANCE-/- newborn mice compared to LN [94]. These results suggest that 
either TRANCE is required for LTi generation or for their recruitment to the LN anlage. 
Interestingly, TRANCE has the capacity to induce LTi cells to upregulate LT in vitro [87]. 
However, the fact that agonistic LTβR Ab injections failed to restore LN development in 
TRANCE-/- mice [94], indicates that TRANCE activity is not solely related to induction of LT 
expression.  Mice deficient for TRANCE receptor [95] or for a signaling molecule downstream 
of TRANCE named TNF Receptor associated Factor 6 (TRAF6) [87] do not develop LN. It was 
shown that in TRAF6-/- embryos, LTi cells fail to cluster at the site of LN anlage [87]. LN 
formation can be partially rescued by intraembryonic injection of IL-7 [87]. It is still not clear, 
whether in this experimental setting, IL-7 restores LN development by upregulating LT on LTi 
cells or/and by increasing LTi cell number. 
 
2.8.2 Chemokines 
The chemokine family also plays a central role in LN organogenesis. For instance, mice 
deficient for the chemokine CXCL13 [96] or its cognate receptor CXCR5 [97], lack several 
peripheral LN. Furthermore, in mice deficient for lymphoid chemokines or chemokine receptors 
such as CXCL13-/- plt/plt mice [91] and in CXCR5-/- CCR7-/- mice [98], peripheral and mucosal 
LN are completely absent. Altogether, these results indicate that the chemokine-mediated 
recruitment of LTi cells to the LN anlage is a crucial step in LN organogenesis.  
 
2.8.3 NFκB pathways 
Engagement of the LTβR activates the non-classical NF-κB pathway, which leads to the 
translocation of p52/RelB heterodimers into the nucleus. The disruption of the non-classical NF-
κB leads to a complete absence in LN. For instance, aly/aly mice, which have a naturally arising 
mutation in the NF-κB inducing kinase (nik) gene, lack all LN and PP [99, 100]. In the same 
line, RelB-/- mice have a very severe defect in LN development [101, 102], further indicating a 
crucial role for the non-classical NF-κB in LN organogenesis. These phenotypes likely result 
from the impairment of organizer cells to produce chemokines in response to LTβR engagement 
and therefore from the failure to recruit sufficient numbers of LTi cell to the LN anlage.  
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LTβR engagement also triggers the classical NFκB pathway, which leads to the 
translocation of p50/RelA heterodimers into the nucleus. p50 deficiency does not affect LN 
development [103]. RelA deficiency is embryonically lethal because of TNFR1-mediated signals 
inducing apoptosis of hepatocytes. In contrast, mice double deficient for RelA and TNFR1 are 
viable [104]. While TNFR1-/- mice have normal LN development [69], TNFR1-/- RelA-/- mice 
lack all LN, suggesting that RelA plays a crucial role in LN organogenesis. [104]. TNFR1-/- 
RelA-/- embryos have normal numbers of LTi cells, which express normal levels of LT, 
indicating that the LN defect is rather due to a deficiency of the mesenchymal compartment. 
Indeed, p50/RelA heterodimer is known to induce expression of adhesion molecules such as 
VCAM-1, ICAM-1and MAdCAM-1 [104], and might therefore be required for the generation of 
functional organizer cells. 
 
3.  Characterization of TSLP gene and protein 
 
3.1  Identification and cloning of TSLP  
The conditioned medium from the murine medullary thymic cell line Z210R.1 was shown 
to support the differentiation of FL cells towards the B cell lineage and the growth of the pre-B 
cell line NAG8/7 [105]. Fractioning this conditioned medium by chromatography revealed that 
this activity was independent of IL-7 and suggested the existence of a novel cytokine. This 
cytokine was named thymic stromal lymphopoietin (TSLP) [105]. Murine TSLP was cloned by 
generating a cDNA library from the Z210R.1 cell line and by screening the supernatant of cells 
transfected with cloned cDNAs for TSLP activity [106].  
Human TSLP was identified computationally from the murine sequence [107] and from 
searches through sequences of the IL-7 helical cytokine family [108]. 
 
3.2 TSLP gene structure  
Murine TSLP consists of 140 amino acids (Aa) of which 121 were predicted to correspond 
to the mature murine TSLP and 19 correspond to signal peptides [106]. TSLP contains 7 cysteine 
residues and 3 possible sites for N-linked glycosylation addition [106]. There is a putative site of 
mRNA polyadenylation [106]. Upon expression in mammalian cells, recombinant TSLP protein 
shows a 23kD major species and an 18kD minor species [106].  As the cDNA sequence 
prediction gives a MW of 14 kD for TSLP, the observed differences in MW are likely the result 
of differential N-linked glycosylation events [106].  
Human TSLP protein is only 43% identical to the murine protein [107, 108]. The human 
TSLP sequence is 740 bp long, which encodes a protein of 159 Aa [107, 108]. The mature TSLP 
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protein and the signal sequence are respectively 131 and 28 Aa long. Human TSLP contains 2 
sites for N-linked glycosylation, none of which are conserved between mouse and human TSLP 
[107, 108]. While human TSLP MW is predicted at 14.9 kD, practically, it resolves at 23 kD, 
suggesting that it is indeed glycosylated [108]. All of the 6 cysteines present in murine TSLP are 
conserved in the human TSLP sequence [107]. Disulfide bonds between cysteine pairs are also 
conserved between man and mouse [107].  
 
3.3 TSLP genomic location and expression pattern 
The murine TSLP gene localizes on chromosome 18 [106]. The human TSLP gene 
localizes on chromosome 5, at a position that is syntenic with murine chromosome 18 [107].  
According to Northern blot and RT-PCR analysis, murine TSLP is expressed at high levels 
in thymus and lungs and at lower levels in spleen, LN, BM but not in PP, brain, liver nor heart 
[106]. Upon activation with protease allergen, murine basophils were shown to release TSLP 
[109].  
In humans, Northern blot analysis revealed that TSLP mRNA is expressed at higher levels 
in heart, liver, prostate and testis while it is expressed at lower levels in lung, skeletal muscle, 
kidney, spleen, ovary, small intestine and colon [107]. TSLP mRNA expression was investigated 
in human primary cells [110]. The only hematopoietic cells reported to express large amount of 
TSLP mRNA are mast cells (MC) upon IgεR cross-linking [110]. TSLP was found to be mainly 
expressed in bronchial and mammary epithelial cells and in keratinocytes [110]. At the protein 
level, human TSLP was reported to be expressed by the epithelial cells of the Hassall’s 
corpuscules [111, 112], the keratinocytes from chronic and acute AD lesions [110], by epithelial 
cells from inflamed tonsils [111] and by the epithelium of bronchial biopsies from asthmatic 
patients [113].  
 
3.4 Regulation of TSLP expression 
Since TSLP expression in human biopsies often correlated with allergic diseases, most of 
the effort to understand the conditions leading to its expression were concentrated on primary 
human epithelial cells. Hence, it was shown that human airway epithelial cells release the TSLP 
protein in response to IL-1 and TNF-α and to the TLR ligands PolyI:C and bacterial 
peptidoglycans [114]. Human bronchial epithelial (HBE) cells upregulate TSLP mRNA and 
release TSLP protein upon stimulation with inflammatory cytokines such as TNF-α, IL-1β, IL-
4/TNF-α and IL-13/TNF-α but also with TLR ligands such as lipoteichoic acid, Poly(CpG), 
CpG-B and Poly I:C [115, 116]. The NF-κB site in the promoter of the tslp gene is crucial for 
production of TSLP in response to PolyI:C [115] and to IL-1β [116]. Consistent with the fact 
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that IL-4 and double stranded RNA synergized for TSLP production [115], the infection of HBE 
cells by rhinovirus in presence of exogenous IL-4 also led to the production of TSLP [115]. 
Altogether, these results suggest that inflammatory cytokines, TH2 cytokines, microbes and 
viruses might induce the release of TSLP by airway and bronchial epithelial cells. 
There are few studies on TSLP expression by human skin. However, several mouse models 
have provided insights into the requirements and the conditions under which TSLP is expressed 
in the skin. Combination of IL-4, IL-5, IL-13 and TNF-α induced the production of TSLP by 
human skin keratinocytes [117], suggesting that “inflammatory TH2” cells might be able to 
induce TSLP production in inflamed skin. In mice deficient for Retinoid X receptor (RXR)α and 
RXR-β specifically in epidermal keratinocytes, TSLP was overexpressed in the skin leading to 
an AD-like disease [118]. These results show that RXR are required for direct or indirect 
inhibition of the tslp gene expression and for preventing AD-like disease [118]. Skin application 
of vitamin D3, which is a ligand of vitamin D receptor, induces the expression of TSLP by 
keratinocytes [119]. Application of vitamin D3 on the skin of RXRα-/- RXRβ-/- mice does not 
increase TSLP expression, suggesting that Vitamin D3 signals through the same pathway as 
RXR [119]. Specific deletion of Notch signaling in the skin results in a defect of skin barrier 
formation and subsequently the production of TSLP in the skin [120]. Altogether, these results 
suggest that breakdown in skin homeostasis, epithelial stress or inflammation might induce 
TSLP production in the skin. 
 
4. TSLPR cloning and characterization  
 
4.1 Cloning of TSLPR 
The biological effect of TSLP requires IL-7Rα but not γc [121, 122], indicating that an 
unknown subunit is part of the TSLP receptor. Several approaches were undertaken in order to 
identify and clone this subunit. Recombinant murine TSLP was iodinated in order to screen cells 
that expressed TSLP receptor [122]. The cDNA from a murine T cell line, which bound 
iodinated TSLP was cloned [122]. The cDNA clones were transfected into mammalian cells and 
the relevant subunit of the TSLP receptor was identified from the cells binding the radiolabelled 
TSLP. Analysis of the cDNA from these TSLP-binding cells provided the first sequence of this 
subunit called TSLPR [122]. TSLPR was otherwise identified through search of sequences 
homologues to the cytoplasmic domain of the erythropoietin receptor in the EST database from 
NCBI [123]. Different groups identified and cloned human TSLPR gene by searching genomic 
database for homologies with human γc and/or with murine TSLPR sequences [108, 124, 125]. 
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Similarly, rat TSLPR sequence was identified by searching sequences homologous with mouse 
TSLPR in the EST database [126]. 
 
4.2 TSLPR structure 
TSLPR belongs to the type I cytokine receptors [107, 123-125, 127]. All of the receptors 
from this family are type I membrane glycoproteins, with the N terminal region outside of the 
plasma membrane and with a single hydrophobic transmembrane domain [128]. The 
extracellular domain, which is also the ligand-binding domain, is the most conserved region 
throughout the family. It usually contains 4 cysteines, which are conserved among the family, a 
fibronectin type III module and, just outside of the membrane spanning domain, a conserved 
Trp-Ser-X-Trp-Ser (WSXWS) domain [128, 129]. A box 1 domain, which is proline rich and 
important for the binding of the Janus family kinase (Jak) is present in the cytoplasmic domain 
[129].  
Murine TSLPR was predicted to be either 359 [122, 127] or 370 [123] Aa long. The sixth 
exon contains two potential splice acceptor sites [126], explaining the difference of length in Aa 
observed between the first studies presenting the cloning of the tslpr gene. TSLPR contains 2 
potential sites for N-linked glycosylation [122, 123]. While the predicted molecular mass of 
TSLPR is 37kD, its actual value is approximately 50 kD, indicating that TSLPR undergoes N-
linked carbohydrate addition [123]. TSLPR contains a signal peptide at the NH2 terminus and a 
single membrane-spanning domain [122]. TSLPR shows a fibronectin type III-like domain, but 
only 2 of the 4 conserved cysteine residues are present [127]. The TSLPR cytoplasmic domain 
contains a box 1 region [122]. The exons of the murine tslpr gene are organized similarly to 
those of the γc chain [126]. Both genes contain 8 exons, of which the first contains the signal 
peptides, the sixth codes for the transmembrane domain and the last two code for the 
cytoplasmic domain [126].  
The human TSLPR protein contains 371 Aa, and has a predicted molecular mass of 39.7 
kD [124, 125]. As for the mouse, the predicted Aa sequence for human TSLPR contained a 
cytokine receptor module with 2 of the 4 conserved cysteine residues [125], 4 potential N-linked 
glycosylation sites, a fibronectin type III-like domain, a WSXWS motif, a single transmembrane 
domain and an intracellular “box 1” motif [124, 125].  
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4.3 TSLPR genomic location and expression pattern 
Tslpr gene maps to the central region of chromosome 5 [122, 126, 127] and the human 
tslpr gene is present on chromosome Xp22.3 and Yp11.3 [124].  
Northern blot analysis reveals that murine TSLPR is expressed in thymus, spleen, brain, 
heart, kidney, skeletal muscle, liver, lung, testis and BM [122, 123, 127]. TSLPR mRNA was 
also detected in various myeloid cell lines, in Th1 and at high levels in Th2 cell lines [127]. 
While Northern blot analysis gave contradictory results about human TSLPR expression 
pattern [124, 125], RT-PCR and real time PCR analysis showed that TSLPR is expressed in 
activated DC, in monocytes and in some T cell lines [108]. While it is absent from the surface of 
resting cells, TSLPR protein is upregulated on activated human T cells [130]. Besides, TSLPR is 
expressed, together with IL-7Rα, by MCs [114].  
 
4.4 TSLP Receptor signaling  
The receptor for murine and human TSLP is composed of the IL-7Rα chain and TSLPR 
[107, 108, 121-123]. Murine TSLP receptor signaling is independent of the γc chain [121, 122]. 
As for IL-7, TSLP-mediated signaling triggers tyrosine phosphorylation of both signal 
transducers and activators of transcription (STAT)5a and STAT5b proteins [121]. TSLP receptor 
signaling leads to the translocation of functionally active STAT5 proteins into the nucleus [131]. 
Importantly, STAT5 activity is required for TSLP receptor signaling, as a dominant negative 
version of STAT5 prevents TSLP-mediated signal transduction [131].  In contrast to IL-7, TSLP 
does not induce the phosphorylation of Janus kinase (Jak)1 nor of Jak3 [131]. Indeed, a 
dominant negative version of Jak1 does not prevent TSLP signaling [131].  While most of the 
molecular players involved in TSLP receptor signaling are still unknown, SOC-1, which is a 
negative feedback regulator of the Jak/STAT pathway, and the Tec family kinases might be 
implicated in the TSLP receptor signaling pathway [131].  
Less is known about human TSLP receptor signaling, but TSLP stimulation was shown to 
induce the phosphorylation of STAT5 [107, 108] and of STAT3 [108] but not of Jak3 [107]. 
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5. TSLP Activity 
 
5.1 TSLP activity on B cells 
 
5.1.1 In vitro B cell development 
Murine TSLP was first identified for its capacity to sustain the growth of the pre-B cell 
line NAG8/7 [105]. These results indicated that TSLP might sustain B cell development in vitro. 
TSLP was later shown to support the growth of colonies in whole BM cultures in a similar 
fashion as IL-7 [106]. This activity was not observed in B220-depleted BM, indicating that 
TSLP was acting on B-cell precursors and not on BM myeloid cells [106]. In line with this, 
TSLP was shown to support the differentiation of uncommitted FL and BM precursors towards 
the B-cell lineage [106, 132].  
In contrast to IL-7 that supports the development of FL or BM cells into B220+ IgM- pre-B 
cells, TSLP rather promoted the generation of B220+ IgM+ [121]. Based on these in vitro results, 
TSLP and IL-7 were proposed to differentially affect B cell development: IL-7 would promote 
the accumulation of pre-B cells while TSLP would rather support immature B cell development 
[121].  
 
5.1.2 In vivo B cell development   
Several gain of function approaches clearly identified the capacity of TSLP to sustain B 
lymphopoiesis. For instance, intra-peritoneal (i.p.) injections of recombinant TSLP in 7 days old 
mice led to the increase in percentage of pre-B cells in the BM [106]. In a TSLP Tg model, the 
absolute number of pro-B, pre-B and immature B cells in the BM was increased [133]. While 
both pro-B/pre-B-I and pre-B-II cells co-express TSLPR and IL-7Rα, pre-B-II cells were 
identified as the main TSLP-responsive population [133]. These results demonstrate that TSLP 
has the capacity to favor B lymphopoiesis, but the question remained whether endogenous TSLP 
is able to promote B cell development under physiological conditions. TSLPR deficiency does 
not affect neither pro-B, pre-B nor immature B cell number in 17.5 dpc FL [134] and adult BM 
[135], ruling out that TSLPR-mediated signals are crucial for B lymphopoiesis in fetal and adult 
life.  
At 4 weeks of age, pre-B cells are detectable in the BM of γc-/- mice while they are absent 
in IL-7Rα-/- mice, indicating that endogenous TSLP might promote residual B cell development 
in young γc-/- mice [136]. The fact that pre-B cells are no longer present in the BM of 8-week old 
γc
-/- animals, suggests that TSLP promotes B cell development during perinatal but not adult life 
[136]. Limiting dilution experiments showed that pro-B cells isolated from RAG2-/- FL cells but 
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not from adult RAG2-/- BM are TSLP-responsive. The difference in TSLP-responsiveness 
between adult and fetal precursors was interpreted as the explanation for the discrepancy in B 
cell development between young and adult γc-/- mice [136]. Cell limiting dilutions experiments 
showed that CD19+ pro-B cells from adult RAG2-/- BM failed to respond to TSLP [137]. On the 
contrary, CD19+ precursors from RAG2-/- mice that carry a Tg coding for the immunoglobulin 
heavy chain, and that therefore express the pre-BCR, were TSLP-responsive [137]. These results 
led the authors to speculate that pre-BCR was required for adult BM precursors to be TSLP-
responsive. 
IL-7Rα-/- mice have lower absolute pro-B, pre-B and immature B cell number in the BM 
than IL-7-/- mice [135]. However, 3 week-old IL-7-/- TSLPR-/- mice have identical number of 
pro-B and pre-B cells and significantly lower numbers of immature B cells than IL-7-/- controls. 
These results show that the endogenous TSLP activity may explain the phenotypic differences in 
immature B but not the pro-B/pre-B compartments of IL-7-/- and IL-7Rα-/- mice [135]. In line 
with this, at 17.5 dpc, the FL of IL-7-/- TSLPR-/- embryos have no further reduction in pro-B and 
pre-B cell number compared to IL-7-/- fetuses [134].  
Chimera experiments showed that HSC isolated from IL-7Rα-/- FL could differentiate into 
B cells while HSCs isolated from adult IL-7Rα-/- BM could not [138]. These results suggest that 
fetal progenitors can generate B cells independently of IL-7 and TSLP and that IL-7Rα signals 
are differentially required for generating B cells during fetal and adult life.  
 
5.1.3 Peripheral B cell compartments  
In a Tg model, high concentration of TSLP in the serum increased the proportion of B220+ 
CD93+ immature and follicular B cells in the spleen while the MZ compartment was lacking 
[133]. While these experiments showed that TSLP has the capacity to alter peripheral B cell 
compartments, they did not address its putative function in physiological concentrations. Neither 
the absolute mature B cell number [135], nor the ratio of IgM+/IgD+ cells [139] differ between 
the spleen of TSLPR-/- and WT animals, showing that TSLP does not play a non-redundant role 
in peripheral B cell homeostasis. However, several lines of evidence suggest that TSLP might 
contribute to B cell homeostasis. For instance, a residual splenic B220+ population present in 
Jak3-/- mice was absent from Jak3-/- TSLPR-/- mice [139]. Splenic mature B cell number is 10 
times lower in IL-7Rα-/- mice compared to γc-/- mice [136], suggesting that endogenous TSLP 
promotes B cell accumulation independently of IL-7. Indeed, IL-7-/- TSLPR-/- mice have 
significantly lower numbers of mature B cells in the spleen than IL-7-/- controls [135]. Together 
these results showed that endogenous TSLP is not crucial for B cell homeostasis but might 
contribute to it in the absence of IL-7. 
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5.1.3 TSLP and B-1 cells 
In reconstitution experiments, IL-7Rα-/- FL precursors generate 10-fold less B-1 cells in 
the peritoneum of RAG2-/- γc-/- recipient than γc-/- precursors, suggesting that TSLP might play a 
role in B-1 cell generation and/or homeostasis [137]. It was reported that adult and fetal BM 
lineage- B220- CD19+ progenitors gave rise to B-1 cells upon transfer in vivo. In the presence of 
TSLP, these progenitors can differentiate in vitro towards cells with a B-1 cell-like phenotype 
and expand without losing their reconstitution potential [140]. Adult TSLP Tg mice have 
increased percentage of B-1b in the peritoneal cavity in respect to control mice [133]. As B-1 
cells do not express IL-7Rα and are therefore unresponsive to TSLP, it was proposed that TSLP 
was rather acting on the lineage- B220- CD19+ B-1 progenitors. Indeed, TSLP Tg expression 
increases absolute numbers of lineage- B220- CD19+ progenitors [133]. Mice that overexpress 
TSLP from fetal life onwards, have increased number of both B-1a and B-1b cells in the 
peritoneum 2 weeks after birth but show an exclusive increase in B-1b cells 4 weeks after birth 
[133]. These results unambiguously show that TSLP has the capacity to generate B-1 B cells 
and/or to contribute to their homeostasis. However, they did not answer the question whether 
endogenous TSLP plays a substantial role in vivo. 
The number of lineage- B220- CD19+ cells was normal in the BM of TSLPR-/- newborn 
mice [135], ruling out an essential function for TSLP in supporting the generation or 
maintenance of this population. Furthermore, B-1 B cell progenitor cell numbers were not 
further decreased in IL-7-/- TSLPR-/- compared to IL-7-/- controls [135], showing that endogenous 
TSLP does not contribute to the generation and/or maintenance of B-1 B cell progenitors. In line 
with this, γc-/- TSLPR-/- and γc-/- mice display similar numbers of peritoneal B-1 B cells [141], 
confirming that the B-1 cell pool is not regulated by TSLP.  
 
5.1.4 TSLP and B-cell lymphoproliferative disorder 
TSLP stimulates the proliferation and inhibits the apoptosis of murine and human acute 
lymphoblastic leukemia (pre-B ALL) cells [142] and of the human acute myeloid leukemia 
(AML)-derived cell line MUTZ-3 [107]. These results indicate that TSLP might sustain the 
development of both lymphoblastic and myeloid leukemia. This hypothesis is supported by a 
murine model in which prenatal and perinatal overexpression of TSLP leads to the expansion of 
B220+ CD43- IgM- pre-B cells and eventually to lethal B-cell lymphoproliferative disorder (B-
LPD) [120]. TSLP was proposed to promote B-LPD only during the perinatal period because 
such disease was absent in animals overexpressing TSLP later than 2 weeks after birth [120]. 
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5.2 TSLP activity and dendritic cells 
Unexpectedly for a cytokine initially discovered for its ability to promote B cell 
development in vitro [105], TSLP turned out to be a potent maturation factor for human and 
murine dendritic cells (DC). In fact, upon TSLP stimulation, human DC upregulate MHC class II 
molecules, the activation markers DC-LAMP, CD40, CD80 and CD86, and produce the CCR4 
ligands CCL17 (TARC) and CCL20 (MDC) [108, 110-112, 143, 144]. In the murine system, 
TSLP induced the upregulation of CD80, CD86 and of MHC class II molecules on DC surface 
[145-147] and promote CCL17 release [147]. TSLP-activated DC can prime naïve CD4+ T cells 
from human and murine origin [110, 145], formally showing that TSLP acts as a maturation 
factor for DC.  
 
5.3  TSLP activity on T cells 
 
5.3.1 Thymopoiesis 
Several evidences showed that TSLP could support T cell development in vitro. 
Recombinant TSLP increased the total thymocyte number in fetal thymus organ culture (FTOC) 
experiments [148]. Moreover, the percentage of DN1 and DN2 cells incorporating BrdU was 
increased, suggesting that TSLP promoted their proliferation [148]. In line with this, TSLP was 
shown to support DN thymocyte proliferation in synergy with IL-1β [106] and, in 2 weeks 
FTOC, the numbers of DN1 and DN2 cells from TSLPR-/- lobes were lower than those of WT 
controls [148].  
Daily injection of recombinant TSLP into WT and γc-/- mice can transiently increase 
thymic cellularity [141], demonstrating that TSLP has the capacity to promote T lymphopoiesis. 
However, thymus cellularity, percentage and number of DN, DP, CD4 SP and CD8 SP cells are 
normal in TSLPR-/- mice [139, 141]. Detailed analysis of DN cells showed that none of the DN 
compartments were affected by TSLPR deficiency [149], suggesting that endogenous TSLP does 
not significantly contribute to adult T cell development. However, thymus cellularity and the 
number of DN3, DN4, DP, CD4 SP and CD8 SP thymocytes in IL-7Rα-/- mice are significantly 
lower than those of IL-7-/- mice [149], suggesting that TSLP might play a role in T 
lymphopoiesis in absence of IL-7. To clarify this issue, mice deficient for both IL-7 and TSLPR 
were analyzed [149]. Absolute thymocyte number, DN, DP, CD4 SP and CD8 SP cell number 
were identical in IL-7-/- mice and IL-7-/- TSLPR-/- animals, demonstrating that endogenous TSLP 
does not substantially participate to T lymphopoiesis [149]. These results suggest that there 
might exist a yet unidentified alternative ligand for IL-7Rα, or that others pathways might 
“cross-activate” IL-7Rα. 
26
  
5.3.2  Regulatory T cells 
The first evidences suggesting that TSLP might be involved in Treg generation arose from 
studies in the human system. Human TSLP-activated DC induce the upregulation of FoxP3 
mRNA in CD4+ CD8- thymocytes. They also promote the differentiation of CD4+ CD25+ T cells 
from CD4+ CD8- CD25- thymocytes [112]. The resulting CD4+ CD25+ T cells share functional 
features of Treg as they do not proliferate in response to anti-CD3/anti-CD28 stimulation and 
inhibit CD4+ CD25- T cell proliferation in vitro [112]. Human Hassall’s corpuscles were 
reported to express TSLP and to be associated with activated DC [112]. Based on the fact that 
TSLP-activated-DC promote Treg development in vitro, it was proposed that TSLP, by 
activating medulla DC, might indirectly induce Treg differentiation in humans. However, as it 
was shown later for peripheral CD4+ T cells [130], the possibility that TSLP acts directly on 
CD4 SP thymocytes might have been underestimated. 
TSLP was also reported to promote Treg generation in mice. However, in the murine 
system, TSLP would act rather on T cells than on DC. For instance, FTOC experiments showed 
that TSLP increases the percentage and absolute cell number of CD4+ CD25+ FoxP3+ Treg [150]. 
Moreover, TSLP promoted the upregulation of FoxP3 mRNA in purified CD4 SP thymocytes 
[150]. In line with this, the percentage of FoxP3+ cells within CD4+ CD25+ population was 
higher in thymocyte cultures in the presence of TSLP [146]. The percentage of DO11.10 
thymocytes, which differentiated towards a CD4+ CD25+ FoxP3+ phenotype in presence of 
OVA-presenting APC, was 2-fold increased in presence of TSLP [146]. In contrast to the human 
system [112], TSLP-activated CD11c+ DC fail to induce the differentiation of CD4+ CD8- CD25- 
thymocytes into Treg [146]. Together with the fact that TSLP induce FoxP3 expression in 
purified CD4 SP thymocytes, these results show that murine TSLP promotes Treg development 
by acting directly on the CD4 SP thymocytes [146, 150]. 
 
5.3.3 Peripheral T cell compartments 
TSLP-activated human DC promote the expansion of autologous naïve CD4+ T cells in the 
absence of exogenous Ag, while DC stimulated with other compounds, such as CpG, Poly I:C or 
CD40L fail to do so [111]. These results suggest that, in humans, TSLP might promote 
peripheral T cell expansion indirectly by activating DC. 
In mice, TSLP injection increases CD4+ T cell number in the spleen of γc-/- mice indicating 
that TSLP promotes CD4+ T cell expansion [141]. In addition, TSLP favors the proliferation and 
the survival of TCR-stimulated CD4+ T cells in vitro [141, 145], demonstrating that TSLP acts 
directly on murine T cells. This was confirmed by the fact that CD4+ T cells isolated from WT 
mice expanded more than TSLPR-/- CD4+ T cells when injected into sublethally irradiated γc-/- 
recipients [141]. However, absolute numbers and percentages of splenic CD4+ and CD8+ T cells 
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were identical in TSLPR-/- and WT mice [139, 141], showing that TSLP does not have a crucial 
role neither on CD4+ nor CD8+ T cell homeostasis. 
 
5.3.4  TH2 differentiation 
Human TSLP-activated DC were shown to prime naïve CD4+ T cell in allogeneic mixed 
lymphocyte reactions [110], demonstrating that TSLP can act as a potent DC maturation factor. 
Furthermore, naïve CD4+ T cells primed with TSLP-activated DC differentiated towards an 
“inflammatory TH2” phenotype. Indeed, the resulting T cells produced IL-4, IL-5, IL-13 and the 
pro-inflammatory cytokine TNF-α, but neither IL-10 nor IFN-γ [110]. Naïve CD8 T cells primed 
with TSLP-activated DC produced IFN-γ, TNF-α, IL-5 and IL-13 but were weakly cytotoxic 
[143]. DC primed with TSLP upregulate the expression of OX40L at both the mRNA and 
protein level [144]. This is of importance, because OX40L signals are mandatory for the priming 
of naïve CD4+ T cells towards the “inflammatory TH2” phenotype [144]. Altogether, these 
results suggest that TSLP indirectly promotes the differentiation of CD4+ and CD8+ T cells 
towards the “inflammatory TH2” phenotype by activating DC. 
Recent findings showed that TSLPR expression is upregulated upon CD4+ T cell activation 
[130]. In contrast to resting cells, activated human CD4+ T cells express TSLPR and 
phosphorylate STAT5 upon TSLP stimulation [130]. As TSLP increases the level of CD25 
expression on activated T cells, it allows them to increase their IL-2 responsiveness [130]. 
Hence, CD4+ T cells activated in the presence of TSLP proliferate better than cells without 
exogenous cytokine [130]. The fact that TSLPR expression is upregulated upon CD4+ T cell 
activation [130], suggest that TSLP could also directly affect T cell differentiation. 
It seems that TSLP influences murine T cell differentiation by acting on the T cell itself 
and independently of DC. For instance, purified murine naïve CD4+ T cells activated with plastic 
bound anti-CD3 in the presence of TSLP differentiated towards IL-4, IL5 and IL13-producing 
TH2 cells [151]. TSLP-mediated TH2 differentiation was dependent on IL-4 and STAT-6 [151]. 
In an in vivo model of allergy, TSLP was instrumental for the subsequent priming of naïve CD4+ 
T cells towards the TH2 phenotype in response to cysteine protease allergen [109]. Indeed, 
inhibition of TSLP activity with neutralizing Ab blocked the TH2 differentiation [109]. The TH2 
differentiation was not accompanied by the upregulation of OX40L by DC, suggesting that 
TSLP promoted TH2 differentiation by acting directly on T cells [109]. 
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5.4 TSLP and allergic diseases 
 
5.4.1 Atopic Dermatitis (AD) 
Skin explants from lesions of AD patients contain very high levels of TSLP protein [110]. 
The Langerhans cells in AD tissues show an activated phenotype and are found in the dermis, 
while control sections show inactivated Langerhans cells in the epidermis [110]. TSLP-activated 
Langerhans cells might play a crucial role in the initiation and the maintenance of AD, because 
they have the capacity to prime naïve CD4+ T towards an “inflammatory TH2” phenotype [110, 
152]. The “inflammatory TH2” phenotype results from the TSLP-mediated OX40L upregulation 
by DC [144]. Most of the AD lesion-infiltrating T cells express the prostaglandin D2 receptor 
CRTH2 and have a TH2 phenotype [153]. TSLP-activated DC induce the expansion of such 
CRTH2+ CD4+ T cells [153], suggesting that TSLP mediates the maintenance of detrimental 
TH2 cells. Hence the current model is that keratinocyte derived-TSLP triggers AD by activating 
skin-homing DC and Langerhans cells, which in turn prime naïve CD4+ T cells towards an 
“inflammatory TH2” phenotype and promotes the expansion of pro-allergic CRTH2+ cells.  
Several animal models support this scenario of AD pathogenesis. For example, mice 
overexpressing TSLP in the skin develop an AD-like disease [118, 154] with epidermal 
hypertrophy, hyperkeratosis, and mononuclear cell infiltrates [154]. Skin sections showed 
infiltrates of eosinophils, MCs and lymphocytes and the accumulation of Langerhans cells in the 
dermis, but not in the epidermis [154]. CD4+ T cells from TSLP Tg mice showed a TH2 
phenotype, as they expressed IL-4, IL-5 and TNF-α but no INF-γ upon restimulation [154]. 
Levels of IgE and IgG1 were highly increased in TSLP Tg animals compared to non-Tg 
littermates [154]. Intradermal injection of TSLP in mice leads to ear thickness and increased 
serum IgE levels [155]. All of these effects can be diminished by continuous injection of 
neutralizing anti-OX40L Ab [155], suggesting that OX40L might play a crucial role in TSLP-
mediated AD. 
Importantly, several murine models showed that B and T cells do not play a crucial role in 
the development of TSLP-mediated AD. For instance, AD-like disease developed in TCRβ-/- 
mice overexpressing TSLP in the skin, as shown by massive infiltration by eosinophils and MCs 
[154]. Induction of TSLP in the skin by application of Vitamin D3 led to an AD-like disease in 
RAG-/- mice [119], demonstrating that T and B cell presence is not required for the initiation and 
development of AD.  
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5.4.2 Allergic asthma 
In lung biopsies from asthmatic patients there was an increase in mRNA and protein of 
TSLP, CCL17 and CCL22 compared to non-asthmatic controls [113]. In this study, the main 
producers of these molecules were epithelial cells [113]. It was proposed that TSLP produced in 
lung epithelial cells might play a crucial role in asthma pathogenesis by triggering TH2 
differentiation and recruitment of TH2 effectors [113]. In line with this hypothesis, mice 
overexpressing TSLP in the lungs developed an asthma-like disease characterized by abnormal 
cellular infiltrates in the lung [147]. Lung infiltrates were composed of eosinophils and CD4+ T 
cells, most of which had a TH2 phenotype and express CCR4 [147]. TSLP Tg mice had 
increased IgE levels in the serum compared to non-Tg littermates and showed a severe 
remodeling of airways [147]. These results suggest that TSLP might play an important role in 
triggering and/or sustaining allergic asthma.  
In an OVA-induced allergic asthma model, intranasal challenge with OVA increases TSLP 
mRNA in the lungs and TSLP concentrations in the bronchoalveolar lavage (BAL) of WT mice 
[147]. Upon OVA challenge, WT controls show perivascular inflammation, cell hyperplasia, 
infiltration of eosinophils and neutrophils, high levels of IL-5 and IL-13 in BAL and high levels 
of IgE in the serum [145, 147]. On the contrary, OVA-challenged TSLPR-/- mice do not develop 
symptoms of asthma [145, 147], showing that endogenous levels of TSLP play indeed a crucial 
role in asthma pathology. Consistently, the treatment with a TSLPR-Fc fusion protein of OVA-
challenged WT mice limited the development of allergic asthma [145]. 
In a murine model of lung inflammation, nasal sensitization with TSLP induces 
recruitment of lymphocytes and eosinophils to the lung, increased levels of the Th2 cytokines 
IL-4, IL-5, IL-13 in the BALs, and increased levels of serum IgE [155]. All of these effects were 
prevented by continuous injection of neutralizing anti-OX40L Ab [155]. In a non-human primate 
model, an asthma-like disease was induced by sensitization with house dust mite (HDM) Ag. 
This induced the expression of TSLP by lung cells [155]. Treatment with a blocking anti-OX40L 
Ab reduced the concentration of IL-5 and IL-13 cytokines in the BALs and the titer of specific 
anti-HDM IgG [155].  
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5.4.3 TSLP and mast cells 
There are several lines of evidence suggesting that TSLP activates MCs, which in turn 
exacerbate inflammation and allergic responses. For instance, combination of IL-1, TNF and 
TSLP stimulates human MCs, which in turn produced the TH2 cytokines IL-5, IL-13, IL-6 and 
the chemokines CXCL8 and CCL1 [114]. Furthermore, in co-culture experiments with biopsies 
from lesions of AD patients, MCs release IL-13 in a TSLP-dependent fashion [114].  
Mouse models showed that MCs can trigger epithelial cells to produce TSLP. Hence, 
induction of rhinitis with OVA leads to the accumulation of TSLP protein in the nasal epithelium 
in a MC-dependent fashion [156]. Importantly, mice with MCs deficient for FcγR (and therefore 
for IgE receptor) do not upregulate TSLP in the epithelium in response to OVA challenge [156]. 
These results suggest that MC regulate TSLP expression in nasal epithelium and might play a 
pivotal role in allergic rhinitis pathogenesis. In this line, neutralizing anti-TSLP Ab decreases 
pathological symptoms of OVA-induced rhinitis [156]. Hence MCs induce the expression of 
TSLP by epithelial cells and respond to it, suggesting that MC might be at the center of a viscous 
cycle promoting inflammatory and allergic reactions. 
 
Altogether, these studies on AD, asthma and rhinitis indicate that TSLP is likely to play a 
central role in the pathogenesis of allergic diseases, and that TSLP or some of its downstream 
effectors such as OX40L represent promising therapeutic targets. 
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C. Aim of the study 
 
While TSLP was identified as a cytokine sustaining B cell development in vitro, its 
function on hematopoiesis in vivo remained elusive. Our first aim was to characterize the 
function of TSLP in adult lymphopoiesis. Several studies suggested that IL-7 and TSLP had 
overlapping activity in vitro. Hence, to study the function of TSLP in vivo, we have generated 
mice overexpressing TSLP on an IL-7 deficient background (manuscript 1).  
 
As there are no data available about the function of TSLP in LN organogenesis, our second 
goal was to characterize the function of TSLP in LN formation and to investigate whether it had 
the capacity to substitute IL-7 in LN development. To answer these questions, we have used IL-
7-/- and RAG-/- γc-/- mice overexpressing TSLP (manuscript 2). 
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D. Results 
 
1. Manuscript 1: 
 
 
 
 
 
Increased TSLP availability restores T- and B-cell compartments in adult IL-7-deficient 
mice 
 
 
S. Chappaz
1
, L. Flueck
1
, A.G. Farr
2
, A.G. Rolink
1
 and D. Finke
1 
 
 
 
1
Center for Biomedicine, Department of Clinical and Biological Sciences (DKBW), University of 
Basel, 4058 Basel, Switzerland 
2
 Department of Biological Structure and Department of Immunology, University of Washington, 
Seattle, WA 98195, USA
33
HEMATOPOIESIS
Increased TSLP availability restores T- and B-cell compartments in adult
IL-7–deficient mice
Stephane Chappaz,1 Lukas Flueck,1 Andrew G. Farr,2 Antonius G. Rolink,1 and Daniela Finke1
1Center for Biomedicine, Department of Clinical and Biological Sciences (DKBW), University of Basel, Basel, Switzerland; and 2Department of Biological
Structure and Department of Immunology, University of Washington, Seattle
Interleukin 7 (IL-7) plays a crucial role in
adult lymphopoiesis, while in fetal life its
effect can be partially compensated by
TSLP. Whether adult hematopoietic pro-
genitor cells are unresponsive to TSLP or
whether TSLP is less available in adult
microenvironments is still a matter of
debate. Here, we show that increased
TSLP availability through transgene (Tg)
expression fully restored lymphopoiesis
in IL-7–deficient mice: it rescued B-cell
development, increased thymic and
splenic cellularities, and restored double-
negative (DN) thymocytes, !" and #$
T-cell generation, and all peripheral lym-
phoid compartments. Analysis of bone
marrow chimeras demonstrated that he-
matopoietic progenitor cells from adult
wild-type mice efficiently differentiated
toward B- and T-cell lineages in lethally
irradiated IL-7 deficient mice provided
TSLP Tg was expressed in these mice. In
vitro, TSLP promoted the differentiation
of uncommitted adult bone marrow pro-
genitors toward B and T lineages and the
further differentiation of DN1 and DN2
thymocytes. Altogether, our results show
that adult hematopoietic cells are TSLP
responsive and that TSLP can sustain
long-term adult lymphopoiesis. (Blood.
2007;110:3862-3870)
© 2007 by The American Society of Hematology
Introduction
Lymphopoiesis is regulated by a number of cytokines that control
the proliferation, differentiation, and survival of hematopoietic
progenitor cells. Among these factors, IL-7 plays an essential role
in B- and T-cell development.1-3 IL-7 signals through the IL-7
receptor that is composed of the common !-chain (!c or CD132)
and the IL-7R" (CD127) chain.4 IL-7R" can also associate with
the thymic stromal lymphopoietin receptor (TSLPR) chain to form
the receptor for the cytokine TSLP.5,6 TSLPR signaling occurs
independently of !c5-7 and does not rely on the phosphorylation of
any known Janus family kinases but leads to the translocation of
functional Stat5 to the nucleus.7,8
TSLP was originally cloned from a murine thymic stromal cell
line.9 While displaying only 43% protein identity,10,11 human and
mouse TSLP share similar biologic functions. Both promote
homeostatic expansion of CD4# T cells,12,13 trigger dendritic cell
maturation,14-16 induce TH2 differentiation,14-18 and are important
factors in triggering inflammatory allergic responses.14-16,18,19
Several studies have suggested that TSLP may play a role in
fetal rather than adult B-cell development. For instance, at 4 weeks
of age, !c$/$ mice, which are responsive to TSLP but not to IL-7,
showed residual B lymphopoiesis. In contrast, in 4-week-old
IL-7R"$/$ mice, which are unresponsive to both TSLP and IL-7,
B-cell development was absent. However, at 12 weeks of age, both
mouse strains were devoid of B lymphopoiesis.20 Moreover,
although both adult IL-7$/$ and IL-7R"$/$ mice lack !% T cells,
fetal IL-7$/$ but not IL-7R"$/$ thymi contained !% T cells.3,21 It is
currently unknown whether these differences reflect distinctive
TSLP responsiveness of fetal versus adult hematopoietic cells, or if
they are the result of decreased availability of a biologically active
form of TSLP in adult mice.
TSLP was shown to support B-cell development in vitro.7,9,22
However, there are conflicting results on the role of TSLP for B-cell
development in vivo. TSLPR$/$ mice had no defect in B-cell
development,12,23 while TSLP Tg expression either promoted24 or
inhibited25 B lymphopoiesis.
Experimental data showing a role for TSLP in T lymphopoiesis
are limited. TSLP could induce a moderate in vitro proliferation of
adult double-negative (DN) thymocytes in synergy with IL-1, but
failed to sustain the proliferation of fetal thymocytes.26 While
TSLPR$/$ mice had no defect in T development, mice lacking both
the !c and the TSLPR chains showed lower thymic cellularity than
!c$/$ mice.12 Moreover, the injection of recombinant TSLP could
transiently increase the number of thymocytes in !c$/$ mice.12
Although these data suggest that TSLP may be involved in
T lymphopoiesis, the developmental stage at which TSLP exerts its
biologic function has not been clearly identified.
To understand the function of TSLP on hematopoiesis in vivo,
TSLP-transgenic (Tg) mice were generated and backcrossed to an
IL-7–deficient background. The TSLP Tg expression was driven by
the keratin 14 (K14) promoter that targets gene expression to
epithelial cells.27
In this study, we show that TSLP Tg expression rescued B-cell
development, increased the thymic cellularity, and rescued the
thymic architecture in IL-7$/$ animals. DN1 and DN2 thymocytes
but also !% T cells developed in response to TSLP. Moreover, adult
WT bone marrow (BM) cells differentiated normally into B and
T lineages and restored peripheral compartments when adoptively
transferred into lethally irradiated IL-7$/$ K14-TSLP Tg recipi-
ents. In addition, we observed a strong effect of TSLP overexpres-
sion on peripheral myeloid cell expansion. In vitro, TSLP promoted
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the generation of B and T lineage cells from early lymphoid/
myeloid BM progenitors and supported the differentiation of DN1
and DN2 thymocytes. Altogether, we show here that TSLP is a
potent cytokine able to support adult B- and T-cell development
and to expand both lymphoid and myeloid compartments in
peripheral lymphoid organs.
Materials and methods
Mice
All mice were bred and maintained in our animal facility under specific
pathogen-free conditions. The animal experiments received the approval of
the Cantonal Veterinary Office of the city of Basel, Switzerland.
C57BL/6 mice were purchased from RCC (Itingen, Switzerland).
IL-7$/$ mice were previously described.1 RAG2$/$ !c$/$ mice on
C57BL/6 background were kindly provided by Jo¨rg Kirberg (MPI, Freiburg,
Germany).
For generation of transgenic mice, the murine TSLP open reading
frame26 was inserted into the pK14pA construct.28 The transgene DNA was
microinjected into fertilized (C57BL/6 & DBA/2) F2 embryos to generate
transgenic founders. Progenies of the founder mice were phenotypically
identical. One line was backcrossed with C57BL/6 mice for at least
8 generations. The genotype of TSLP Tg mice was identified by polymerase
chain reaction (PCR) from genomic DNA with the following primers:
5'-TGCAAGTACTAGTACGGATGGGGC-3' from the 5' coding region
and 5'-GGACTTCTTGTGCCATTTCCTGAG-3' from the 3' coding re-
gion. PCR conditions were 94°C for 2 minutes followed by 34 cycles of
94°C for 30 seconds, 62°C for 30 seconds, 72°C for 30 seconds, and finally
72°C for 5 minutes. PCR products were separated on a 1% agarose gel and
detection of a 323-bp fragment positively identified TSLP Tg presence.
For BM chimera, IL-7$/$ K14-TSLP Tg mice, IL-7$/$ littermates, and
C57BL/6 WT mice were lethally !-irradiated (9 Gy) and intravenously
injected with 107 total BM cells from 8-week-old WT mice (CD45.1#). Six
weeks or 6 months after reconstitution, BM chimeric mice were analyzed.
Immunization
NP stands for 4-hydroxy-3-nitrophenyl-acetyl. Ten- to 12-week-old IL-7$/$
K14-TSLP, IL-7$/$, and C57BL/6 mice were immunized intraperitoneally
with 50 (g alum-precipitated NP-ovalbumin (NP-OVA) or intravenously
with 100 (g NP-Ficoll. Sera were collected prior to immunization and 10 or
14 days after NP-Ficoll or NP-OVA immunization, respectively.
ELISA
NUNC Immunoplate Maxisorb F96 plates (NUNC, Roskilde, Denmark)
were coated with 5 (g/mL NP-BSA at 4°C. Plates were incubated with
serial dilutions of sera for 2 hours at room temperature. After washing,
alkaline phosphatase–conjugated rat anti–mouse IgM (R6–60.2; PharMin-
gen, San Diego, CA) or goat anti–mouse IgG (Southern Biotechnology
Associates, Birmingham, AL) was added to the plates. Plates were
developed with FAST pNPP (p-nitrophenylphosphate; Sigma-Aldrich, St
Louis, MO) according to the manufacturer’s instructions. Serum titers were
determined using the end point titer procedure. TSLP enzyme-linked
immunosorbent assay (ELISA) was performed with the DuoSet ELISA kit
(R&D, Abington, United Kingdom) according to the manufacturer’s
instructions.
Cell culture
OP929 and OP9-DL1 cells30 were cultured as previously described.31 Semiconflu-
ent cultures of stromal cells were !-irradiated (30 Gy) before adding sorted DN1,
DN2, or early progenitors for lymphoid and myeloid progenitors (EPLMs).
Sorted cells (5& 103)/well of a 24-well plate were cultured in supplemented
IMDM on OP9 or OP9-DL1 cells in the presence of either 100 U/mL IL-7 or 500
U/mL TSLP or without additional cytokine. At day 7, cells were harvested,
counted, stained, and analyzed by flow cytometry.
Flow cytometry and cell sorting
FITC-, PE-, PE-Cy7–, APC-, or biotin-conjugated "-CD4 (GK1.5), "-CD8"
(53–6.7), "-CD19 (1D3), "-CD21 (CR2/CR1), "-CD23 (B3B4), "-CD25
(7D4), "-CD44 (IM7), "-CD45.1 (A20), "-!% TCR (GL3), "-V!3 TCR
(536), and "-NK1.1 (PK 136) Abs were purchased from BD Biosciences
(Basel, Switzerland). "-CD3 (145–2C11), "-CD11b (M1/70), "-CD24
(M1/69), "-CD62L (MEL-14), "-B220 (RA3–6B2), "-TER119 (TER-
119), and "-TCR) chain (H57–597) were from Biolegend (San Diego,
CA). "-CD45 (30-F11), "-CD71 (R17217), "-CD117 (2B8), and "-Gr-1
(RB6–8C5) Abs were from eBioscience (San Diego, CA). "-V!1.1-PE
(2.11) and "-V!2-PE (UC3–10A6) were obtained from A. Wilson (LICR,
Epalinges, Switzerland). "-CD93 (PB493) Ab was produced in our
laboratory and labeled with biotin by standard methods. As secondary
reagent, streptavidin-PE and streptavidin-PE/Cy7 (Biolegend) were used.
Flow cytometry acquisition was performed with a FACSCalibur (BD
Biosciences) and data were analyzed using Flowjo software (Tree Star,
Eugene, OR). EPLM sorting was done as previously described.31 Briefly,
erythrocyte-depleted BM cells were sorted as B220# CD19$ CD117#
CD93# NK1.1$ cells. DN1 and DN2 thymocytes were sorted as CD117high
CD25$ CD44# and CD117high CD25# CD44# cells, respectively.32 Cell
sorting was done using a FACS Aria (BD Biosciences) and reanalysis of
sorted cells indicated that they were more than 98% pure.
V(D)J rearrangement analysis
B220#CD19# double-positive cells (5& 105) from IL-7$/$K14-TSLPTg mice
(8 weeks old) were fluorescence-activated cell sorting (FACS) sorted, and
genomic DNA was isolated by standard protocols. DNA amplification was
carried out in 2 rounds of PCR. The first round of PCR amplification contained
5 different 5'VH primers recognizing the VH families VHJ558, VH7183, VHQ52,
VHJ606, VHS107, VHX24, and VHGAM308 together with a nested 3' JH4 primer.
In the second round, 2 (L of the first PCR product was reamplified with a VH
family–specific 5' primer and the same nested 3' JH4 primer. PCR products were
purified on a 1.5% agarose gel by cutting the band with the appropriate size of a
V(D)J rearrangement followed by TA cloning. A set of clones was sequenced
using the Big Dye Terminator method and the automated DNA sequencer 377
(Applied Biosystems, Weiterstadt, Germany). Sequence analysis was performed
with 4Peaks (Apple Computer, http://mekentosj.com/4peaks/), IMGT/JunctionAn-
alysis (The International Immunogenetics Information System, http://imgt.cines.fr/
cgi-bin/IMGTjcta.jv) and IgBLAST (http://www.ncbi.nlm.nih.gov/projects/
igblast/).33
Immunofluorescence confocal microscopy
Acetone-fixed thymic sections (8 (m) were incubated with polyclonal "-K5
(PRB-160B; Covalence, Princeton, NJ), "-CD3-biot (145–2C11; eBioscience),
and "-K8-Cy5 Abs (TROMA-1; Developmental Studies Hybridoma Bank,
University of Iowa) followed by incubation with streptavidin–Alexa 488
(Molecular Probes, Leiden, the Netherlands) and goat "-Rabbit–Alexa 555
(Molecular Probes), and finally embedded in Fluorsave (Calbiochem, San Diego,
CA). Images were captured on a Zeiss LSM 510 Meta Laser Confocal Scanning
Confocal Microscope System (Carl-Zeiss, Fedbach, Switzerland). Overlays of
blue (Cy5), red (Alexa 455), and green (Alexa 488) stainings were colored by
computer-assisted management of confocal generated data with Zeiss LSM 510
software version 3.2.
Quantitative real-time PCR
RNA extraction was performed with the Nucleospin RNA II kit (Macherey-
Nagel, Du¨ren, Germany) followed by DNase digestion with RQ1 RNase-
Free DNase (Promega, Madison, WI). RNA (750 ng) was used to perform
the Reverse Transcription with Oligo dT (Promega) and dNTPs (Roche,
Rotkreuz, Switzerland) with the Superscript III Reverse Transcriptase
(Invitrogen, Carlsbad, CA). Real-time PCR was performed with Sensimix
(Quantace, Watford, United Kingdom) on a Rotor Gene RG-3000 (Corbett
Research, Sydney, Australia). The following primers were used: TSLP
FWD: AGGCTACCCTGAAACTGAG, TSLP RVS: GGAGATTGCAT-
GAAGGAATACC, TBP FWD: CGTGAATCTTGGCTGTAAACT, TBP
RVS: GTCCGTGGCTCTCTTATTCT. TSLP and TBP primer pairs had
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identical efficiency. The cycling conditions for both TSLP and TBP
amplifications were 10 minutes at 95°C, followed by 40 cycles of
10 seconds at 95°C, 15 seconds at 60°C, and 20 seconds at 72°C. The
relative expression of TSLP on TBP was calculated with the comparative CT
(**CT) method.
Isolation of skin-resident lymphocytes
Ears were digested with collagenase IV (Sigma-Aldrich) in HBSS contain-
ing 10 mM Hepes, 2.5 mM CaCl2, and 2% FCS for 30 minutes at 37°C. Cell
suspensions were filtered, stained, and analyzed by flow cytometry.
Statistical analysis
Statistical significance between the individual groups was analyzed using
the unpaired Student t test.
Results
The K14-TSLP Tg rescues B- and T-cell development in IL-7%/% mice
As previously reported,1,2 B lymphopoiesis is dramatically
impaired in adult IL-7$/$ mice as shown by the absence of
CD19# B-cell progenitors in the BM (Figure 1B). To test if
increased TSLP availability could rescue B lymphopoiesis in
IL-7$/$ mice, K14-TSLP Tg mice were generated and back-
crossed to an IL-7$/$ background. Absolute numbers of cells in
the BM of IL-7$/$, WT, and IL-7$/$ K14-TSLP Tg mice were
comparable (Figure 1A). In the BM of IL-7$/$ K14-TSLP Tg
mice, the number of CD19# B cells was restored to WT numbers
(Figure 1B). All B progenitor cell subsets were detectable in
IL-7$/$ mice overexpressing TSLP. The major effect of TSLP
was found in the pro-B/pre-B-I (CD19# c-kit#) cell compart-
ment (4-fold increase in percentage compared with WT con-
trols) and absolute numbers of pro-B/pre-B-I cells were 4-fold
increased (S.C. and D.F., unpublished data, December 2006).
Pre-B-II (CD19# CD25#) cells were present at WT percentages
in IL-7$/$ K14-TSLP Tg mice. Immature (CD19# B220# IgM#)
and mature (CD19# B220## IgM#) B cells in IL-7$/$ K14-
TSLP Tg mice were present in lower percentages than in WT
mice. These results show that TSLP Tg expression was sufficient
to rescue the block of B-cell development in the BM of IL-7$/$
animals. In addition, these results suggest that the major target
cells for TSLP were, similar to IL-7,34 pro-B/pre-B-I cells.
IL-7$/$ mice have reduced thymic cellularity and lack !%
T cells.1,3 The thymus cellularity of IL-7$/$ K14-TSLP Tg animals
was 60-fold increased compared with IL-7$/$ littermates but still
remained 2-fold lower than controls (Figure 1C). Contrary to
IL-7$/$ mice, in which DN1 (c-kithigh CD44# CD25$) and DN2
(c-kithigh CD44# CD25#) thymocytes were absent, IL-7$/$ K14-
TSLP Tg mice showed normal percentages of the DN1 and DN2
subsets (Figure 1D). Moreover, the percentages of DN3 (CD44$
CD25#), CD4# SP, CD8# SP, and double-positive (DP) thymocyte
cells in IL-7$/$ K14-TSLP Tg mice were in the range of WT
controls (Figure 1D). While !% T-cell development was undetect-
able in IL-7$/$ mice, IL-7$/$ K14-TSLP Tg mice had normal
percentages of both mature (CD24lo/$) and immature (CD24high)
thymic !%# T cells (Figure 1D). Indeed, V!2# T and V!1.1#
T cells were generated in IL-7$/$ K14-TSLP Tg mice (Figure 1E).
V!3# T cells, which develop during fetal life and are later found
exclusively in the adult skin,35 were present in the skin of IL-7$/$
K14-TSLP Tg but not in IL-7$/$ mice (Figure 1F).
Figure 1. TSLP Tg expression rescues B- and T-cell development in IL-7%/% mice. IL-7$/$, WT, and IL-7$/$ K14-TSLP Tg mice were analyzed at 12 weeks of age.
(A) Absolute cell number per 2 femurs. (B) Regions indicate the pro-B/pre-B-I (CD19# c-kit#), pre-BII (CD19# CD25#), mature (CD19# B220high IgM#), and immature (CD19#
B220# IgM#) B cells in the BM. Numbers are mean and standard deviation of percentage (n + 5). (C) Absolute thymocyte number and (D) thymocyte profiles of DN1 (c-kithigh
CD44# CD25$), DN2 (c-kithigh CD44# CD25#), DN3 (CD44$ CD25#), DN4 (CD44$ CD25$), DP (CD4# CD8#), and SP (CD4# CD8$, CD4$CD8#) thymocytes as well as of
immature (CD24lo/$ !%#) and mature (CD24# !%#) !% T cells are shown. (E) Pregated on CD4$ CD8$ cells, percentages of V!2 and V!1.1 T cells in the thymus are shown.
(F) Pregated on CD45# cells, percentages of V!3# CD3# cells in the skin are shown. Histograms represent the mean and standard deviation from analyzing 5 animals.
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Mouse strains in which thymocyte development is impaired beyond
the DN1 stage display an abnormal cortex with cortical thymic epithelial
cells (cTECs) coexpressing keratin 5 (K5) and keratin 8 (K8).36,37
Consistent with this, the majority of the cTECs in IL-7$/$ thymi
retained an immature K8# K5# phenotype and numerous cysts were
found in IL-7$/$ thymi (Figure S1, available on the Blood website; see
the Supplemental Materials link at the top of the online article). In
contrast, IL-7$/$ K14-TSLP and WT thymi were devoid of cysts and
showed a normal segregation into K8# K5$ cTECs and K8$ K5#
mTECs. SP thymocytes, which express high levels of CD3, were
localized in the thymic medulla of IL-7$/$ K14-TSLP mice. Hence,
TSLP overexpression substantially increased thymus cellularity, rescued
the generation of ") and !% T cells, and corrected the aberrant thymic
architecture in IL-7$/$ mice.
Peripheral B- and T-cell compartments are normal in IL-7%/%
K14-TSLP Tg mice
IL-7$/$ mice are lymphopenic1 and their spleen cell numbers
were 10-fold less than WT controls (Figure 2A). TSLP Tg
expression in IL-7$/$ mice increased splenocyte numbers by an
average of 20-fold. The percentages of splenic CD4# and CD8#
T cells in IL-7$/$ K14-TSLP Tg mice were below WT
percentages. However, absolute T-cell numbers in IL-7$/$
K14-TSLP Tg mice were normal or, for CD4# T cells, even
beyond WT numbers (Figure 2C). To test if the restoration of
peripheral T cells was a result of egress of thymic emigrants or
peripheral expansion, we tested CD62L and CD44 expression by
splenic CD4# and CD8# T cells. The percentage of naive
(CD62Lhigh CD44low) T cells was clearly higher in IL-7$/$
K14-TSLP Tg mice compared with IL-7$/$ percentages but was
lower than WT percentages (Figure 2D). These results suggest
that the restoration of peripheral T cells in IL-7$/$ K14-TSLP
Tg mice was a result of both restoration of thymic development
and peripheral expansion of T cells. !% T cells were present in
the spleen of IL-7$/$ K14-TSLP Tg animals (Figure 2B) in
numbers corresponding to half that in WT controls (Figure 2C),
indicating that TSLP was less efficient than IL-7 in maintaining
the peripheral !% T-cell pool.
In contrast to IL-7$/$ mice, the absolute number of marginal zone
(MZ) B cells in IL-7$/$ K14-TSLP Tg animals was comparable with
WT mice (Figure 2C). Follicular B- (FB) cell numbers were even
2.5-fold increased compared with controls (Figure 2C). It has been
reported that TSLP promotes the accumulation of myeloid cells in the
spleen.25 In agreement with this, we found a 5- to 6-fold increase in the
absolute number of Gr-1# CD11b# granulocytes (Figure S2). Alto-
gether, these results indicate that TSLP promoted the accumulation of
peripheral T, B, and myeloid cells.
Systemic expression of TSLP in IL-7%/% K14-TSLP Tg animals
The analysis of IL-7$/$ K14-TSLP Tg mice revealed that TSLP
was able to support lymphopoiesis. We therefore investigated in
which organs TSLP was expressed in Tg mice. Quantitative
real-time PCR analysis revealed that, consistently with the K14
promoter specificity, TSLP mRNA was highly expressed in the
skin (30-fold relative increase compared with WT) and thymus
(8-fold) of Tg mice (Figure 3A). Interestingly, a 50-fold increase
in TSLP transcripts was observed in the BM of Tg animals
compared with WT controls. The amounts of TSLP transcripts in
the spleen and mesenteric lymph nodes were not affected by the
Tg expression. In the sera of IL-7$/$ K14-TSLP Tg animals, an
average concentration of 420 pg/mL TSLP was measured, while
TSLP concentrations were less than 20 pg/mL in IL-7$/$ and
WT controls (Figure 3B). Therefore, the rescue of lymphopoi-
esis and of peripheral lymphocyte compartments might be the
result of Tg-mediated increase of TSLP availability in primary
lymphoid organs and in the serum.
Figure 2. TSLP Tg expression restores splenic lymphocyte compartments in IL-7%/% mice. (A) Absolute splenocyte numbers of IL-7$/$, WT, and IL-7$/$ K14-TSLP Tg
(12-week-old). (B) Percentages and (C) absolute cell number of CD4#, CD8#, and !%#CD3# T cells, and CD19#CD93$ mature B cells composed of follicular (CD23# CD21#)
and MZ (CD21high CD23$) B cells are shown. Histograms represent the mean and standard deviation from analyzing 5 animals. *P , .05; **P , .005 (Student t test). (D) Gated
on splenic CD4# and CD8# T cells, CD62L and CD44 expression is shown.
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In B cells of adult IL-7%/% K14-TSLP Tg mice, the IgH locus
contains additional N nucleotides
TSLP was previously shown to support fetal B lymphopoiesis.20 The
rescue of B-cell development in IL-7$/$ K14-TSLP Tg mice could
therefore be due to the effect of TSLP on fetal liver–derived progenitors.
One hallmark of fetal lymphopoiesis is the absence of expression of
terminal deoxynucleotidyl transferase (Tdt) in lymphocyte precursors,38
leading to the generation of B cells that are completely devoid of
N nucleotides at the junctions of their rearranged VDJ immunoglobulin
heavy (IgH) chain genes.39 To test whether the B cells generated in
IL-7$/$ K14-TSLP Tg mice originated from fetal or adult precursors,
we examined whether rearranged IgH genes in B cells of 8-week-old
IL-7$/$ K14-TSLP Tg mice carried N region nucleotide additions.
Table 1 shows that of 26 B-cell clone sequences from IL-7$/$
K14-TSLP Tg adult spleen, all of them displayed N nucleotide
additions. This result indicates that the B lymphopoiesis in adult IL-7$/$
K14-TSLP mice was promoted by the action of TSLP on Tdt# cells and
therefore, most likely on adult BM-derived progenitors.
TSLP supports the differentiation of adult BM progenitor cells
toward lymphoid lineages
To further assess whether the lymphopoiesis observed in IL-7$/$
K14-TSLP Tg mice relied on the differentiation of adult precursors,
we generated BM chimeras by adoptively transferring 107 total BM
cells from adult WT mice (CD45.1#) into lethally irradiated
IL-7$/$ K14-TSLP Tg, IL-7$/$, or WT recipients (CD45.2#).
Six weeks after transfer, donor chimerism was higher than 95% in
all lymphoid organs of each mouse. Donor BM cell numbers were
similar for each of the 3 experimental groups (Figure 4A).
Donor-derived B-cell precursors were almost undetectable in the
BM of IL-7$/$ recipients, whereas all stages of B-cell development
were present in both IL-7$/$ K14-TSLP Tg mice and WT
recipients (Figure 4B). Donor-derived thymocyte numbers were
increased 270-fold in IL-7$/$ K14-TSLP Tg compared with
IL-7$/$ recipients but remained 1.4-fold below numbers of WT
controls (Figure 4C). Similar percentages of donor-derived DN,
CD4# SP, CD8# SP, and DP were found in WT and IL-7$/$
K14-TSLP mice (Figure 4D). The number of donor-derived
splenocytes was substantially increased in IL-7$/$ K14-TSLP Tg
compared with IL-7$/$ hosts (Figure 4E). Normal percentage of
peripheral CD4# T cells, CD8# T cells, and CD19# B cells was
found in reconstituted IL-7$/$ K14-TSLP recipients. In agreement
with our previous data, splenic B cells in IL-7$/$ recipients were
mainly composed of MZ B cells, while those found in IL-7$/$
K14-TSLP Tg and WT recipients were mainly FB cells (Figure 4F).
Figure 3. TSLP is detectable in the serum of IL-7%/% K14-TSLP Tg mice. (A) TSLP
expression in skin, thymus, BM, et al. Each bar displays the mean of values obtained
from cDNA from 2 mice. Results are representative of 3 independent experiments.
(B) TSLP concentration in sera from IL-7$/$, IL-7$/$ K14-TSLP Tg, and WT mice was
quantified by ELISA. Each symbol represents the result from an individual mouse.
The mean of TSLP concentration is indicated.
Table 1. Splenic B cells in IL-7%/% K14-TSLP Tg mice display N nucleotide additions at VDJ junctions
Clone V P N1 P D P N2 P JH4 D element
3 tgtaccgg — gattacg gggc attactatgctatggactactgg SP2.2*01
4 tgtgcaaga — tggg gg tactatgctatggactactgg DQ52*01
5 tgtgcaaga tc ctcg tatgattac gga atggactactgg SP2.2*01
10 tgtgcaaga aggg ttattactacgg c ttactatgctatggactactgg FL16.1*01
12 tgtgcaaga gg gg cctactatagtaac ccagg ggactactgg SP2.x*01
14 tgtgcaaga cgg agtaac — tacgatgctatggactactgg SP2.x*01
16 tgtgcaaga gagaagg attactacggtagtagct — ctatggactactgg FL16.1*01
19 tgtgcaaga aacccc ctacgg G actatgctatggactactgg FL16.2*01
20 tgtgc cct ctatga C tactatgctatggactactgg SP2.2*01, SP2.9*01
23 tgtgcgag ggacaca gggct — ctatgctatggactactgg ST4
24 tgtgcaaga tccc gta Agaagg atgctatggactactgg FL16.1*01, SP2.x,.1,.5,.7,.8
25 tgtgcaaga cg ggga G atgctatggactactgg DQ52*01
28 tgtgcgaga aatttcgcc tattactacggtagtag g actatgctatggactactgg FL16.1*01
32 tgtgcaaga t gggattttag cggta g ttactatgctatggactactgg FL16.1*01
40 tgtgcaaga gaga atgattacgac g gg tactatgctatggactactgg SP2.2*01
50 tgtgcaaga a aactggg g gcg actatgctatggactactgg DQ52*01
51 tgtgcaaga — attactacggtagtag ctc actatgctatggactactgg FL16.1*01
56 tgtgcaa tgacg attactacggtagtagc ggggg actatgctatggactactgg FL16.1*01
57 tgtgcaaga aggaatcg agttact tggg atgctatggactactgg SP2.12*01
58 tgtgcaaga gga tattactacggtagtagc ctctatggg tatgctatggactactgg FL16.1*01
64 tgtgc c ga tctactatggtaac cacggagggg tgctatggactactgg SP2.1*01
65 tgtgcaaga gcg tattactacggtag — tgctatggactactgg FL16.1*01
67 tgtgcaaga tc ggtgg gattacgac agaaggggtc ttactatgctatggactactgg SP2.2*01
73 tgtgcaaga atggaggg tac acttct ctatgctatggactactgg All, except DQ52
75 tgtgcaaga gaga atgattacgac g gg tactatgctatggactactgg SP2.2*01
80 tgtgcaaga tggac tactacggtagtagct gaaggaggg atggactactgg FL16.1*01
Sequences of VHJ558-JH4 rearrangements from 26 individual PCR fragments derived from sorted B220#CD19# splenic B cells of 8-week-old IL-7$/$ K14-TSLP Tg mice
are shown.
— indicates no N nucleotide addition.
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Donor-derived cells were able to develop into TCR!%# T cells in
IL-7$/$ K14-TSLP Tg mice. These results collectively show that
TSLP could efficiently sustain the differentiation of adult BM
progenitors toward both B- and T-cell lineages in vivo. Our data
contrast in vitro studies showing that in adult BM only pre-BCR#
progenitors are able to respond to TSLP.40 RAG2$/$ !c$/$ mice are
unresponsive to IL-7 and hence unable to generate pro-B cells. In
contrast, TSLP Tg expression in adult RAG2$/$!c$/$ mice clearly
promoted pro-B-cell generation in vivo (Figure 4G).
To test whether the K14-TSLP Tg had an additional effect on
erythroid and myeloid compartments, we analyzed BM chimeras
6 months after reconstitution. Percentages and absolute numbers of
donor-derived granulocytes (Gr-1# CD11b#) and erythroblasts
(Ter119# CD71#) were similar in the BM of IL-7$/$ K14-TSLP Tg
and WT recipients (Figure 5A-B). In contrast, a significant increase
in granulocyte and erythroblast numbers was found in the spleen of
IL-7$/$ K14-TSLP Tg mice (Figure 5C,D). Altogether, our results
show that adult BM progenitors efficiently differentiated toward
B and T lineages in response to TSLP and that TSLP promoted the
accumulation of myeloid cells in the spleen.
TSLP promotes B- and early T-cell development from EPLMs in
vitro
The in vivo effect of TSLP prompted us to study whether TSLP
could promote lineage commitment from a lymphoid/myeloid BM
progenitor cell. EPLMs have been identified as B220# CD117#
CD19$ NK1.1$ BM cells that can give rise to both myeloid and
lymphoid lineages.31 To test if TSLP promoted the development of
B and T cells from EPLMs, we plated 5 & 103 FACS-sorted
EPLMs on either OP9 or OP9 stromal cells expressing the Notch
ligand Delta-like-1 (OP9-DL1) and added either TSLP or IL-7.
Figure 4. TSLP sustains the differentiation of WT BM progenitors toward the B- and T-cell lineages in vivo. (A) Absolute cell number per 2 femurs 6 weeks after
reconstitution of lethally irradiated IL-7$/$, WT, and IL-7$/$ K14-TSLP Tg recipients with 107 BM cells (CD45.1#) is shown. (B) FACS profiles were gated on CD45.1# donor
cells. Regions indicate the pro-B/pre-B-I (CD19#c-kit#), pre-B-II (CD19#CD25#), mature (CD19#B220highIgM#), and immature (CD19#B220#IgM#) B cells. Numbers are
mean and standard deviation of percentage (n + 3). (C) Absolute CD45.1# thymocyte number and (D) percentages of donor-derived SP (CD4#CD8$, CD4$CD8#), DP
(CD4#CD8#) thymocytes are shown. (E) Absolute CD45.1# splenocyte number. Histograms represent the mean and standard deviation from analyzing 3 animals. (F) Regions
indicate splenic CD4#, CD8#, and !%# T cells, and CD19# B cells containing follicular (CD23#CD21#) and MZ (CD21high CD23$) B cells. Numbers are mean and standard
deviation of percentage (n + 3). (G) RAG2$/$ !c$/$, WT, and RAG2$/$ !c$/$ K14-TSLP Tg mice were analyzed at 10 weeks of age. Regions indicate the committed
(CD19#B220#) B cells in the BM. Representative FACS analyses of 1 of 3 mice.
Figure 5. TSLP Tg expression leads to the accumulation of granulocytes and
erythroid precursors in the spleen. Six months after reconstitution of lethally
irradiated IL-7$/$, IL-7$/$ K14-TSLP, or WT recipient mice with 1 & 107 BM cells from
CD45.1# mice, recipients were analyzed. All FACS profiles were gated on CD45.1#
donor cells. (A) Granulocytes (Gr-1# CD11b#) and erythroblasts (Ter119# CD71#) in
the BM are shown. (B) Absolute number of granulocytes and erythroblasts in BM.
(C) Granulocytes (Gr-1# CD11b#) and erythroblasts (Ter119# CD71#) in the spleen
are shown. (D) Absolute number of granulocytes and erythroblasts in spleen.
*P , .05; **P , .005 (Student t test). Histograms represent the mean and standard
deviation from analyzing 3 animals.
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EPLMs cultured on OP9 cells without additional cytokine did not
substantially expand (Figure 6A). In contrast, cells cultured with
IL-7 or TSLP underwent a 230- and a 190-fold expansion,
respectively. The majority of EPLMs cultured with either TSLP or
IL-7 had differentiated along the B-cell lineage, as 90% coex-
pressed CD19 and B220 (Figure 6B). When placed on OP9-DL1,
EPLMs cultured with IL-7 or TSLP expanded 150- and 40-fold,
respectively (Figure 6A). TSLP promoted the differentiation of
EPLMs toward the T-cell lineage when cultured on OP9-DL1 cells
(Figure 6B). Indeed, after 7 days of coculture, 76% showed a DN2
(CD25# CD44#) phenotype, whereas 26% had entered the B lin-
eage (CD19# B220#). Comparably, cocultures supplemented with
IL-7 gave rise to 69% DN2 cells and 26% B-committed cells.
These results show that TSLP efficiently supports both B- and
T-cell differentiation from adult lymphoid/myeloid BM progenitors.
DN1 and DN2 thymocytes are responsive to TSLP
We investigated which T-cell progenitors were directly responsive
to TSLP. DN1 (Figure 6C,D) or DN2 (Figure 6C,E) cells were
FACS sorted and cultured on OP9-DL1 stromal cells either alone or
in the presence of TSLP or IL-7. Sorted DN1 cells cultured for
1 week with IL-7 underwent a 250-fold expansion, whereas cells
cultured with TSLP expanded 100-fold (Figure 6C). Most of the
cells had progressed to the DN2 stage after a culture period of
7 days (Figure 6D). DN2 cells grown in the presence of IL-7 or
TSLP expanded 220- and 70-fold, respectively (Figure 6C). After
7 days in medium supplemented with TSLP, 15% of the originally
sorted DN2 cells had a DN3 (CD25# CD44$) phenotype, whereas
83% retained the DN2 phenotype (Figure 6E). Similar results were
obtained from culturing DN2 cells with IL-7. Taken together, these
results show that TSLP is able to promote the expansion and
differentiation of adult DN1 and DN2 thymocytes in vitro.
IL-7%/% K14-TSLP Tg mice efficiently mount Ab responses to
T-independent and T-dependent Ags
The functionality of B and T cells developing in IL-7$/$ K14-
TSLP Tg mice was assessed by immunization with the T-
independent Ag NP-Ficoll or the T-dependent Ag NP-OVA. Ab
titers in preimmune sera from IL-7$/$ K14-TSLP Tg mice and
IL-7$/$ mice were higher compared with preimmune sera from WT
mice (Figure 7A). Ten days after intravenous immunization with
100 (g NP-Ficoll, IL-7$/$ mice failed to mount a significant
anti–NP IgM response. In contrast, IL-7$/$ K14-TSLP Tg animals
mounted a clear anti–NP IgM response reflected by a 10-fold
increase in specific Ab titer (Figure 7A), an increase similar to that
seen in WT controls.
When immunized with 50 (g of the T-dependent Ag NP-OVA,
IL-7$/$ K14-TSLP Tg mice showed an increase in anti–NP IgG
titers (Figure 7B). These results indicated that both B and T cells
generated in IL-7$/$ K14-TSLP Tg mice were functional and could
effectively collaborate in mounting an Ab response to a T-
dependent Ag. Further investigation will be required to understand
the mechanisms underlying the high variation in anti–NP IgG titers
observed in IL-7$/$ K14-TSLP Tg immunized mice. Taken to-
gether, our results show that B and T cells generated in IL-7$/$
K14-TSLP Tg mice were functional.
Discussion
Mouse models for studying the function of TSLP have left several
questions unanswered regarding its role in adult B- and T-cell
differentiation and myeloid cell expansion. We show here a
so-far-unappreciated capacity of TSLP to promote B- and T-cell
Figure 6. TSLP promotes the expansion and the differentiation of EPLMs, and DN1 and DN2 cells in vitro. (A) Absolute cell numbers harvested after a 7-day culture
period of EPLMs (B220# CD19$ NK1.1$ CD117# CD93#) on either OP9 or OP9-DL1 cells in the presence of TSLP or IL-7, or without additional cytokine. (B) The percentage of
CD19# B220# B cells, DN1 (CD25$ CD44#), DN2 (CD25# CD44#), and DN3 (CD25# CD44$) T-cell precursors is shown. Data shown here are from 1 representative
experiment of 2. (C) Sorted DN1 (CD25$ CD44# CD117high) or DN2 (CD25# CD44# CD117high) cells were plated on OP9-DL1 in the presence of TSLP or IL-7, or without
additional cytokine. Absolute cell numbers were calculated after 7 days of culture. Flow cytometric analysis of (D) DN1 or (E) DN2 cells cultured for 7 days on OP9-DL1 in the
presence of TSLP or IL-7. Data shown here are from 1 representative experiment of 2.
Figure 7. NP-specific Ab titers in the sera of immunized mice. Ten- to
12-week-old IL-7$/$ K14-TSLP Tg, IL-7$/$, and C57Bl/6 mice were immunized and
sera were analyzed as indicated. Each symbol represents the result from an
individual mouse. Filled symbols represent titers prior to immunization; empty
symbols represent titers after immunization. (A) Titers of NP-specific IgM prior and
10 days after intravenous NP-Ficoll immunization. (B) Titers of NP-specific IgG titers
prior and 15 days after intraperitoneal NP-OVA immunization.
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development in adult mice. BM lymphoid/myeloid progenitors as
well as DN thymocytes were responsive to TSLP. In the absence of
IL-7, TSLP overexpression was able to restore central and periph-
eral lymphoid compartments and to amplify myeloid cells in the
periphery.
TSLP mRNA is expressed at low levels in primary lymphoid
organs26 and TSLP concentrations are low (, 20 pg/mL) in the
serum of WT and IL-7$/$ mice41,42 (Figure 3). These endogenous
TSLP levels fail to overcome IL-7 deficiency. Here, we show that
TSLP serum concentrations of 420 pg/mL were sufficient to
compensate for the lack of IL-7. While even lower levels of TSLP
affect B-cell development in a WT background,24 the minimal
concentration that is required locally or in the serum to sustain
lymphopoiesis in absence of IL-7 remains to be determined.
TSLP overexpression restored all stages of B-cell differentia-
tion in the BM of IL-7$/$ mice (Figure 1B). Adoptively transferred
adult WT BM progenitors replenished all B-cell compartments in
BM and spleen of IL-7$/$ K14-TSLP Tg recipient (Figure 4).
Together with the finding that IgH junctions of B cells displayed
N regions (Table 1), our data indicate that adult BM progenitors
were responsive to TSLP. This is further supported by the fact that
TSLP induced the differentiation of adult EPLMs toward CD19#
B cells in vitro (Figure 6). In addition, pro-B cells developed in
RAG2$/$ !c$/$ mice in response to TSLP Tg expression (Figure
4G). These results contrast a previous study showing that in vitro,
pre-BCR expression was required for adult B-cell precursors to be
TSLP responsive.40 The differences in our findings might be a
result of different requirements for B-cell development in vitro and
in vivo.
This study further shows that TSLP promotes the differentiation
of adult BM progenitors toward T-cell lineage in vitro (Figure
6A,B) and that DN1 and DN2 cells are directly responsive to TSLP
(Figure 6D-E). TSLP Tg expression restored DN1 and DN2
thymocyte compartments in IL-7$/$ mice (Figure 1D) and normal-
ized the organization of the thymus (Figure S1). Since DN
thymocytes play a crucial role in cTEC maturation,36,37 our results
suggest that the TSLP-driven generation of DN1 and DN2 cells
corrected cTEC differentiation in IL-7$/$ mice. TSLP Tg expres-
sion also rescued the generation of !% T cells. In IL-7$/$ fetal
thymus, V!3# T cells are generated but do not persist in the adult.3
The presence of V!3# T cells in the skin of IL-7$/$ K14-TSLP Tg
mice shows that TSLP could replace IL-7 in maintaining the
dendritic epidermal V!3# T cells.
The effect of TSLP on in vitro and in vivo thymocyte expansion
was lower compared with IL-7. This could be due to a less
stimulatory activity of TSLP on thymocytes. Indeed, TSLP has a
weaker effect on "-CD3 stimulated SP thymocytes than IL-7.12
Alternatively, it is possible that the frequency of TSLP-responding
precursors might be lower than those of IL-7–responding precursors.
In the spleen, however, absolute T-cell numbers were restored
and CD4# T cells were even significantly increased in IL-7$/$
K14-TSLP mice compared with WT controls. A substantial percent-
age of CD4# and CD8# T cells in IL-7$/$ K14-TSLP Tg mice
showed a naive CD62L# CD44$ phenotype, indicating that they
were recent thymic emigrants. On the other hand, 44% of CD4#
and 23% of CD8# T cells in IL-7$/$ K14-TSLP mice showed a
CD44high activated phenotype (Figure 2D), suggesting that TSLP-
driven peripheral T-cell expansion could compensate for the
relatively low thymic output. This result might explain the high
variation of NP titer observed in T-dependent Ab response (Figure
7B), as activated T cells might be less efficient in their helper
function.
The robust accumulation of FB cells in response to TSLP
overexpression confirms previous results in K5-TSLP Tg mice24
and is reminiscent of the effect of IL-7.43 In addition, TSLP
promoted the accumulation of myeloid precursors in the spleen.
Whether this is a direct or indirect in vivo effect of TSLP remains to
be clarified. High systemic concentration of TSLP in )-actin–TSLP
Tg mice leads to myeloid hyperplasia in the spleen and, surpris-
ingly, impairs lymphopoiesis.25 In contrast, we find that TSLP can
sustain T and B lymphopoiesis. This discrepancy might be a result
of significantly lower amounts of TSLP Tg expressed in our mouse
model. It will be important to elucidate the mechanism by which
high amounts of TSLP inhibit lymphopoiesis.
Altogether, our data demonstrate that TSLP can promote adult
B and T lymphopoiesis, restore peripheral lymphocyte compart-
ments, and induce peripheral accumulation of myeloid cells. The
compromised lymphopoiesis found in IL-7$/$ mice might there-
fore not be due to the inability of adult hematopoietic cells to
respond to TSLP but is rather a consequence of limited TSLP
availability.
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Supplemental Figure 1. TSLP Tg expression restores thymic architecture in IL-7-/- mice.  
Immunofluorescence analysis of thymi from IL-7-/- K14-TSLP Tg mice, IL-7-/-littermates 
and WT controls stained for CD3 (green), Keratin 5 (red) and Keratin 8 (blue). Original 
magnification: x20. 
 
Supplemental Figure 2. TSLP Tg expression  induces the accumulation of granulocytes in 
the spleen. 
IL-7-/- K14-TSLP Tg mice, IL-7-/-littermates and WT controls were analyzed at 12 weeks 
of age. (A) Granulocytes (Gr-1+ CD11b+) in the BM are shown. (B) Absolute granulocyte 
numbers in BM. (C) Granulocytes in the spleen are shown. (D) Absolute cell numbers of 
granulocytes in spleen. (**), p<0.005 (Student’s t-test). Histograms represent the mean and 
standard deviation from analyzing 5 animals. 
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Abstract  
 
Lymph node (LN) organogenesis is initiated by the interaction between the hematopoietic 
lymphoid tissue inducer (LTi) cells and mesenchymal organizer cells. Mice deficient for 
molecules of the IL-7 signaling pathway have a severe defect in LN development. It is known 
that IL-7 regulates the size of the LTi cell pool but the reasons underlying the defective LN 
formation in these mice are unknown. Here, we show that overexpression of thymic stromal 
lymphopoietin (TSLP) increases LTi cell numbers and restores LN development in IL-7-/- and 
RAG2-/- γc-/- mice. LN anlagen from RAG2-/- γc-/- TSLP Tg are devoid of B, T and NK cells 
showing that colonization of the LN by peripheral lymphocytes is not required for persistence of 
LN anlage. In contrast, our results suggest that LTi cell number is a critical parameter for LN 
organogenesis. Indeed, increased LTi cell number restored organizer cells and LN in RAG2-/- γc-/- 
TSLP Tg mice. Altogether these results identify LTi and organizer cells as the minimal cellular 
players required for LN organogenesis and indicate that the LN defect in IL-7-/- and RAG2-/- γc-/- 
mice is the consequence of insufficient LTi cell numbers.  
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Introduction 
 
The development of LN relies on the crosstalk between hematopoietic CD4+ IL-7Rα+ 
lymphoid tissue inducer (LTi) cells and VCAM-1+ ICAM-1+ mesenchymal organizer cells. As 
early as 12.5-13.5 days post-coitum (dpc), LTi cells start to cluster at sites of nascent LN anlagen 
[87]. These cells are crucial for LN formation, as RORγ-/- mice, which lack LTi cells, are 
completely devoid of LN [80]. LTi cells express lymphotoxin (LT) α1β2 and engage the LTβ 
receptor present on organizer cells, which subsequently form clusters [87]. The absolute 
requirement for the LTab/LTbR interaction between LTi and organizer cells is illustrated by the 
fact that LTα-/-, LTβ-/- and LTβ receptor (LTβR)-/- mice lack all peripheral LN [62, 64, 66]. 
LTβR signaling induces the expression of adhesion molecules and chemokines [90], recruiting 
more LTi cells to the nascent LN anlage. After birth, the LN anlage is progressively colonized by 
mature lymphocytes, which later segregate into B cell follicles and a T cell zone [157].  
Besides LT, interleukin 7 (IL-7) plays a central role in LN organogenesis. Mice with a 
defect in the IL-7 signaling pathway, such as JAK3-/-, γc-/-, IL-7-/- and IL-7Rα-/- mice, have severe 
defects in peripheral LN development [91, 92, 158, 159] and have impaired B and T 
lymphopoiesis  [6, 7]. IL-7 signals through the IL-7 receptor, which is composed of the IL-7Rα 
(CD127) and the common γ (γc) chains. γc is also a crucial component of the IL-15 receptor that 
is required for NK cell development [158].  
We have previously shown that thymic stromal lymphopoietin (TSLP) is a cytokine that 
has overlapping biological activity with IL-7 on adult lymphopoiesis in vivo [160]. TSLP signals 
through a unique receptor formed by IL-7Rα together with a γc-like chain called TSLPR [122]. 
TSLP signaling is independent of γc and mediates STAT5 phosphorylation [121]. While the 
physiological levels of TSLP in IL-7-/- mice are not sufficient to sustain lymphopoiesis, its 
overexpression is sufficient to restore both B and T cell compartments [160]. 
The reasons underlying the absence of LN in IL-7-/- and γc-/- mice remain elusive. IL-7 
availability regulates the size of the pool of LTi cells in vivo [92]. Indeed mesenteric LN (mLN) 
from newborn IL-7Rα-/- mice contain decreased LTi cell numbers compared to WT mice [91], 
suggesting that LN organogenesis might be defective in IL-7-/- and γc-/- mice because of low LTi 
cell numbers. An alternative explanation is that LN organogenesis occurs normally but that 
lymphopenia prevents the maintenance of the LN anlage after birth [161].  
In this study, we have investigated whether overexpression of TSLP could restore LN 
organogenesis in mice deficient for the IL-7 signaling pathway. Furthermore, we addressed 
whether LN development in IL-7-/- and γc-/- mice results from an early intrinsic defect in LN 
organogenesis or from the lack of colonization by peripheral lymphocytes.  
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We show here that IL-7-/- and RAG-/- γc-/- mice bearing a K14-TSLP transgene had almost 
normal LN numbers. In RAG-/- γc-/- TSLP Tg mice, in which B, T and NK cells are absent, LN 
development was restored, ruling out that peripheral lymphocytes were required for LN 
development. TSLP Tg expression in IL-7-/- and RAG-/- γc-/- mice increased LTi cell numbers, 
restoring organizer cells in RAG-/- γc-/- mice and rescuing LN formation. Our results further show 
that some of the mesenchymal and endothelial compartments forming the LN microenvironment 
are dependent on lymphocyte presence while others are not. 
 
Results and discussion 
 
TSLP Tg expression rescues LN development in IL-7-/- mice. 
In IL-7-/- mice LN development is severely impaired [92]. We addressed whether increased 
TSLP availability could restore LN development in IL-7-/- mice. Adult IL-7-/- K14-TSLP Tg 
mice and non-Tg littermates were i.p. injected with Chicago Blue and analyzed 7 days later. 
Except for sacral and deep cervical LN, almost all peripheral LN were present in IL-7-/- mice 
overexpressing TSLP (Fig1.A-B). Mesenteric LN were found in all animals analyzed regardless 
of TSLP Tg expression (Fig1.A). These results show that TSLP Tg expression has the capacity 
to substitute IL-7 for LN organogenesis and extend our previous data on the overlapping activity 
of IL-7 and TSLP in adult lymphopoiesis [160]. 
As IL-7Rα is almost exclusively expressed by hematopoietic cells, LN restoration in IL-7-/- K14-
TSLP Tg animals was likely mediated through the effect of TSLP on hematopoietic cells. Hence, 
to gain insight into the mechanism underlying the restoration of LN development in IL-7-/- K14-
TSLP mice, we investigated which hematopoietic cells were affected by TSLP Tg expression. 
TSLP overexpression restored B and T cell compartments in the spleen of 4.5 day old IL-7-/- 
mice compared to littermate controls (Fig 1.C) with CD19+ B220+ B cell numbers increased 
about 100 fold (Fig 1.D). CD4 and CD8 T cell numbers were increased 18 and 20 fold, 
respectively, while NK cells were less affected. These results show that TSLP overexpression 
increased the size of B, T and NK cell compartments in the periphery of newborn IL-7-/- mice. In 
the newborn spleen of IL-7-/- K14-TSLP Tg mice, the percentage of CD4+ IL-7Rα+ LTi cells was 
3-fold increased as compared to non-Tg littermates (Fig1.E). LTi absolute cell numbers were 
3.8-fold and 2-fold increased in the spleen and the mLN, respectively (Fig 1.F-G).  
As LTi cell function relies on the expression of LT, we analyzed LTα1β2 expression by 
LTi cells from newborn IL-7-/- K14-TSLP Tg and non-Tg littermates. We found that LTi cells 
from both origin expressed similar levels of LTα1β2 (Fig 1.H). These result show that TSLP Tg 
expression increases LTi cell numbers in vivo, without altering LTα1β2 expression levels.  
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To address whether LTi cells were instrumental for the restoration of LN in IL-7-/- K14-
TSLP Tg mice, IL-7-/- K14-TSLP Tg mice were backcrossed to RORγ-/- mice. IL-7-/- RORγ-/- 
K14-TSLP Tg newborn mice were devoid of LTi cells (Suppl. Fig.1) and LN were missing in 
adults (Table I). Thus, TSLP-mediated LN restoration in IL-7-/- mice was dependent on LTi 
cells.  
 
TSLP activates LTi cell progenitors in the fetal liver. 
In order to understand the mechanism underlying the increase in LTi cell number in IL-7-/- 
K14-TSLP Tg mice, we investigated whether LTi cells or their fetal liver (FL) precursors were 
TSLP-responsive by monitoring STAT5 phosphorylation in response to TSLP stimulation in 
vitro. 14.5 dpc lin- α4β7+ c-kit+ FL progenitors expressed TSLPR on their surface (Suppl. 
Fig.2A) and a substantial fraction phosphorylated STAT5 in response to TSLP (Suppl. Fig.2B). 
LTi cells expressed low levels of TSLPR (Suppl. Fig.4C) and in contrast to IL-7, they did not 
phosphorylate STAT5 in response to TSLP (Suppl. Fig.2D). While IL-7 favored the generation 
of LTi cells from FACS sorted lin- α4β7+ c-kit+ FL cells, we failed to detect a similar activity of 
TSLP in various in vitro settings (data not shown). We therefore investigated whether TSLP can 
promote the generation of LTi cells from FL progenitors in vivo. To this end, we reconstituted 
lethally irradiated Ly5.2+ IL-7-/- K14-TSLP Tg adult and non-Tg littermates with WT 106 FL 
Ly5.1+ cells from 12.5 dpc embryos. 10 days after reconstitution, the percentage of LTi cells 
from donor origin was substantially higher in TSLP Tg recipients than in non-Tg littermates 
(Suppl. Fig.2E), Consistently, LTi absolute cell numbers were increased approximately 5 fold in 
the spleen of IL-7-/-K14-TSLP Tg recipients compared to non-Tg littermates (Suppl. Fig.2F). 
These results suggest that increased availability of TSLP increases the number of LTi cells in 
vivo most likely through an effect on FL precursors. 
 
Increase in LTi cell number restores organizer cell and LN development in RAG2-/- 
γc
-/- mice. 
Peripheral lymphocytes were proposed to play a role in the maintenance of the LN anlage 
during postnatal life [161]. Since we could not rule out that restoration of peripheral 
lymphocytes partially contributed to the LN restoration in IL-7-/- K14-TSLP Tg mice, we 
generated RAG2-/- γc-/- K14-TSLP Tg mice. The fact that TSLP signals independently of γc gave 
us the opportunity to dissect the relative contribution of peripheral B, T, NK and LTi cells in LN 
organogenesis in IL-7-/- K14-TSLP Tg mice. By crossing the K14-TSLP Tg mice on a RAG2-/- 
γc
-/- background, we generated mice devoid of B, T and NK cells but with increased LTi cell 
numbers. Consistent with our findings in newborn IL-7-/- K14-TSLP mice, the percentage of 
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CD4+ IL-7Rα+ LTi in the spleen was 2-fold increased in RAG2-/- γc-/- K14-TSLP Tg newborn 
mice compared to non-Tg littermates (Fig2.A). Absolute LTi cell numbers were 2 fold increased 
in the spleen and mLN of TSLP Tg newborn mice compared to non-Tg littermates (Fig.2B-C). 
The level of LTα1β2 expressed by LTi cells was similar in the spleen and mLN of newborn 
RAG2-/- γc-/- K14-TSLP Tg and of non-Tg littermates (Fig.2D). In 7 day old WT mice, mLN 
were colonized by CD45+ hematopoietic cells of which the vast majority were CD4+ and CD8+ T 
cells with some CD19+ B220+ B cells (Fig2.E). In contrast, LN from both RAG2-/- γc-/- K14-
TSLP Tg mice and from non-Tg littermates were devoid of lymphocytes. 
Adult RAG2-/- γc-/- K14-TSLP Tg and non-Tg littermates were analyzed for the presence of 
LN. As expected, RAG2-/- γc-/- mice had a severe defect in LN development with the frequency 
of inguinal, politeal, para-aortic, axillary, pancreatic and hepatic LN below 20% that of WT mice 
(Fig.2F-G). TSLP overexpression fully restored inguinal, popliteal, axillary, and hepatic LN 
development and substantially rescued the organogenesis of para-aortic LN (Fig.2F, 2G.II and 
2G.IV). The formation of brachial, superficial cervical and deep cervical LN was also clearly 
enhanced by TSLP Tg expression. Hence, RAG2-/- γc-/- K14-TSLP Tg animals had almost normal 
LN numbers. These results show that peripheral B, T and NK lymphocyte compartments are not 
required for the maintenance of LN anlage. In this line, the depletion of NK cells with NK1.1 
antibody (Ab) for the first 2 weeks of life of RAG2-/- mice did not prevent the normal formation 
of LN (data not shown). 
TSLP overexpression increased LTi cell numbers and restored LN development in RAG2-/- 
γc
-/- mice. Since LTi cells are mandatory for the formation of organizer cell clusters [81, 87], 
these results suggested that the increase in LTi cell number might have a direct effect on the 
organizer compartment. To test this hypothesis, we analyzed inguinal LN (iLN) anlage from 
RAG2-/- γc-/- K14-TSLP Tg and non-Tg newborn mice. Consistent with the absence of peripheral 
lymphocytes, iLN from both RAG2-/- γc-/- and RAG2-/- γc-/- K14-TSLP Tg animals contained few 
CD45+ cells (Fig.2H). Within the CD45- fraction, a homogenous VCAM-1+ ICAM-1+ organizer 
population was present in TSLP Tg animals while it was absent from non-Tg littermates 
(Fig.2H). These results suggest that the TSLP-mediated increase in LTi cell numbers is 
instrumental for the restoration of organizer cells in newborn RAG2-/- γc-/- mice and later for the 
restoration of LN in adult. These results further indicate that organizer cells are dependent on 
LTi cell number and suggest that LN development is defective in IL-7-/- and RAG2-/- γc-/- animals 
because of suboptimal LTi cell numbers.  
Our data are in line with the previously proposed idea [81, 94, 162] that there is a threshold 
number under which LTi cells fail to effectively “instruct” LN stroma. There are indeed several 
lines of evidence indicating that low LTi cell numbers fail to induce proper LN development. For 
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instance, mice that were reported to have decreased LTi cell numbers in their LN anlage, such as 
TRANCE-/- mice, do not develop LN [94]. In addition, the maintenance of a fetal LN 
transplanted under the kidney capsule of an adult mouse is dependent on the number of LTi cells 
[162]. A 15 dpc LN fails to persist unless exogenous LTi cells are added to the graft, whereas 17 
dpc LN, containing more LTi cells, persists without LTi addition [162]. Furthermore, mice in 
which LTi cell recruitment to the LN anlage is impaired are devoid of LN [91, 99].  
LTα is required for the generation, the survival and the proliferation of organizer cells [81, 
87, 162]. However, the fact that agonist LTβR Ab treatment restores LN development in LTα-/- 
mice [163] but fails to do so in LTi-deficient mice [81, 94] demonstrates that LTi cells provide 
additional signals that are independent of LTα. Altogether, our results support the idea that the 
regulation of LTi cell numbers by cytokines is crucial for LN organogenesis, because LTi cells 
provide LT-dependent and independent signals, which are crucial for the organizer cell 
compartment. 
 
Absence of LN in RAG2-/- γc-/- is independent of lymphopenia. 
To test whether the lymphopenia of RAG2-/- γc-/- mice was responsible for the failure to 
detect LN, we reconstituted adult sub-lethally irradiated RAG2-/- γc-/- K14-TSLP (Ly5.2+) mice 
and RAG2-/- γc-/- (Ly5.2+) littermate controls with Ly5.1+ WT BM cells. Four weeks after 
reconstitution, peripheral B, T and NK cells were present in high numbers in the spleen of both 
Tg and non-Tg recipients, showing the efficient replenishment of peripheral compartments upon 
BM reconstitution (Suppl. Fig.3A-B). The LN repertoire in RAG2-/- γc-/- K14-TSLP Tg and 
RAG2-/- γc-/- recipients was identical to that of non-chimeric mice (Suppl. Fig.3C). These results 
show that the absence of detectable LN in RAG2-/- γc-/- adult mice was not a result of 
lymphopenia.  
 
Inguinal LN from RAG2-/- γc-/- K14-TSLP Tg mice share features of WT LN. 
The LN microenvironment is composed of different stromal populations, which contribute 
to the LN framework and actively participate to adaptive immunity. For instance, the LN 
microarchitecture is maintained by a stromal network that can be visualized by staining with an 
Ab specific for the ER-TR7 antigen [56]. Structures such as capsule, high endothelial venules 
(HEV), cortex and medulla were readily detectable in iLN from both WT and RAG2-/- γc-/- K14-
TSLP mice (Figure 3.A-B). ER-TR7 staining clearly resolved B and T cell zones in WT LN 
while these areas could not be discriminated in LN of RAG2-/- γc-/- K14-TSLP mice (Figure 3.A-
B). As previously shown in mice devoid of B cells [164], HEV were rather localized below the 
subcapsular sinus of the LN. While present within the WT B cell follicles, no CR1+ networks of 
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follicular dendritic cells (FDC) were detected in the LN of RAG2-/- γc-/- K14-TSLP animals 
(Figure 3.C-D). As FDC generation is dependent on LT and TNF signals [165], these results 
indicate that lymphocytes provide crucial LT and TNF signals for the development of FDC 
network. As expected in WT LN [51, 52], the B and T cell stroma were positively stained for the 
B-cell attractant CXCL13 and the T-cell attractant CCL19, respectively (Figure 3.E and 3.G). 
Similarly to what observed in SCID mice [157], staining for CXCL13 in RAG2-/- γc-/- K14-TSLP 
iLN was found along the subcapsular sinus, while CCL19 positive staining was observed in 
inner parts of the LN (Figures 3.F and 3.H). As for WT, iLN from RAG2-/- γc-/- K14-TSLP mice 
was encapsulated by Lyve-1+ lymphatic endothelium (Figure 3.I and 3.K). The vast majority of 
CD31+ vascular vessels within the LN from RAG2-/- γc-/- K14-TSLP animals were positive for 
the addressin PNAd, indicating that HEV developed in the absence of peripheral lymphocytes 
(Figure 3.J and 3.L). Altogether, our results suggest that some mesenchymal and endothelial 
compartments, which form the LN microenvironment, develop normally in absence of 
lymphocyte while others critically require lymphocyte presence. 
Taken together, our results show that the increased availability of TSLP can restore LN 
development in IL-7-/- and RAG2-/- γc-/- mice through increase in LTi cell numbers. Our results 
shed light on the minimal cellular players required for LN development during ontogeny as they 
show that the presence of LTi and organizer cells but not of peripheral lymphocytes is critical for 
LN persistence. They further underscore that there is a threshold under which LTi cells fail to 
instruct LN stroma. In fact, the TSLP-mediated increase in LTi cell number was sufficient to 
restore the organizer cell compartment and LN development in RAG2-/- γc-/- mice. Altogether, 
our findings support the idea that the crucial role played by IL-7 and γc in LN organogenesis is 
mediated exclusively through the regulation of LTi cell number. 
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Figure Legends 
 
Figure 1. Increased TSLP availability restores LN development in IL-7-/- mice. (A) 
Quantification of LN in IL-7-/- and IL-7-/- K14-TSLP Tg littermates. 8 to 11 mice were analyzed 
per group. (B) Para-aortic region of IL-7-/- (I) and IL-7-/- K14-TSLP Tg (II) littermates. (C) 
FACS analysis of splenocytes from 4.5 days old IL-7-/- and IL-7-/- K14-TSLP Tg mice. Gates 
indicate B220+ CD19+ B cells, NK1.1+ NK cells and CD8+ and CD4+ T cells. Numbers are mean 
and standard deviation of percentages. (D) Absolute cell number of B, NK, CD4 and CD8 T 
cells in 4.5 days old IL-7-/- and IL-7-/- K14-TSLP Tg mice. Histograms represent the mean and 
standard deviation from analyzing 5 animals per group. (E) Representative FACS plots of IL-7-/- 
and IL-7-/- K14-TSLP Tg newborn spleens (0.5 days old). Numbers are mean and standard 
deviation of percentages. Absolute CD4+ CD3- IL-7Rα+ LTi cell number in spleen (F) and mLN 
(G) of IL-7-/- (circle) and IL-7-/- K14-TSLP Tg (triangle) 0.5 days old mice. Each symbol 
represents LTi cell numbers from an individual animal. The mean values are indicated by a bar. 
(H) LTα1β2 level expression of WT CD19+ B cells (shaded), LTi cells from newborn IL-7-/- 
(plain line) and IL-7-/- K14-TSLP Tg (dotted line) mice in spleen (left) and mLN (right).  
 
Table I. LN restoration in IL-7-/- K14-TSLP Tg mice is LTi cell-dependent. Adult IL-7-/- RORγ-/- 
K14-TSLP (n=6) mice were analyzed for LN presence together with WT (n=5) controls. 
 
Figure 2. TSLP-mediated increase in LTi cell numbers restores LN development in RAG2-/- γc-/- 
mice. (A) FACS profiles gated on CD3- CD19- cells show the percentage of CD4+ IL-7Ra+ LTi 
cells found in RAG2-/- γc-/- and RAG2-/- γc-/- K14-TSLP Tg newborn spleens (0.5 days old). 
Numbers are mean and standard deviation of percentages. Absolute CD4+ CD3- IL-7Rα+ LTi 
cell number in spleen (B) and mLN (C) of 0.5 day old RAG2-/- γc-/-  (circle) and RAG2-/- γc-/- 
K14-TSLP Tg (triangle) mice. Each symbol represents LTi cell number for an individual animal. 
The numbers are the means indicated by the bar. (D) LTα1β2 expression level of LTi cells from 
LTα-/- (shaded), RAG2-/- γc-/- (plain line) and RAG2-/- γc-/- K14-TSLP Tg (dotted line) newborn 
mice in spleen (left) and mLN (right). (E) Representative FACS analysis of mesenteric region in 
6.5 days old RAG2-/- γc-/-, RAG2-/- γc-/- K14-TSLP Tg and WT mice. Histograms show CD45 
staining. Gates indicate B220+ CD19+ B cells, NK1.1+ CD122+ NK cells and CD8+ and CD4+ T 
cells. Numbers are percentages among cells within the lymphocyte gate. 5 animals were 
analyzed for each group. (F) Quantification of LN present in RAG2-/- γc-/- and RAG2-/- γc-/- K14-
TSLP Tg littermates. 9-13 mice were analyzed per group. (G) Para-aortic region of RAG2-/- γc-/- 
(I) and RAG2-/- γc-/- K14-TSLP Tg (II) littermates. Inguinal region of RAG2-/- γc-/- (III) and 
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RAG2-/- γc-/- K14-TSLP Tg littermates (IV). (H) Representative FACS analysis of iLN anlage in 
2.5 days old RAG2-/- γc-/- and RAG2-/- γc-/- K14-TSLP Tg mice. Gates indicate CD45- non-
hematopoietic cells and, within the CD45- fraction the VCAM-1+ ICAM-1+ organizer cells. 
Numbers are percentages among live cells. 
 
Figure 3. Visualization of LN architecture and stromal compartments. Inguinal LN from adult 
RAG2-/- γc-/- K14-TSLP Tg mouse and from WT control were stained for the fibroblastic reticular 
cell marker ER-TR7 (A-B). CA, capsule; B, B cell zone; T, T cell zone; HEV, High Endothelial 
Venule. Inguinal LN sections were stained with ER-TR7 together with CR1 (C-D), CXCL13 (E-
F), CCL19 (G-H) or Lyve-1 (I and K) or stained for CD31 in combination with PNAd (J and L). 
 
Supplemental Figure 1. Newborn IL-7-/- RORγ-/- K14-TSLP mice lack LTi cells. 
Representative FACS plot of spleen from 0.5 day old IL-7-/- RORγ+/- K14-TSLP and IL-7-/- 
RORγ-/- K14-TSLP mice. 
 
Supplemental Figure 2. Lineage- α4β7+ CD117+ FL progenitors but not LTi cells are TSLP-
responsive. (A) TSLPR expression level of 14.5 dpc lineage- α4β7+ CD117+ FL progenitors 
from TSLPR-/- (shaded) and WT mice (plain line). (B) Sorted 14.5 dpc lineage- α4β7+ CD117+ 
FL progenitors were stimulated in vitro with 100 ng/ml of recombinant IL-7 or TSLP or left 
unstimulated. Levels of STAT5 phosphorylation were assessed by flow cytometry. Numbers 
indicate the percentage of phospho-STAT5+ cells. (C) TSLPR expression level of newborn 
splenic CD4+ CD3- IL-7Rα+ LTi cells and CD4+ CD3+ T cells from TSLPR-/- (shaded) and WT 
mice (plain line). (D) Newborn mLN and adult splenic cells were stimulated in vitro with 100 
ng/ml of recombinant IL-7 or TSLP or left unstimulated. Levels of STAT5 phosphorylation were 
assessed by flow cytometry analysis. (E-F) Lethally irradiated adult IL-7-/- and IL-7-/- K14-TSLP 
Tg CD45.2+ mice were reconstituted with 106 12.5 dpc CD45.1+ FL cells. (E) Representative 
cytometry plots of splenocytes from FL chimera 10 days after reconstitution, previously gated on 
lineage- CD45.2- cells. Numbers indicate percentages. (F) Absolute LTi cell numbers in spleen 
of IL-7-/- and IL-7-/- K14-TSLP Tg recipients (right). 
 
Supplemental Figure 3. LN phenotype in reconstituted RAG2-/- γc-/- and RAG2-/- γc-/- K14-TSLP 
Tg mice. Sub-lethally irradiated RAG2-/- γc-/- and RAG2-/- γc-/- K14-TSLP Tg recipient mice were 
reconstituted with 106 WT CD45.1+ BM cells together with 2x105 regulatory T cells. Four weeks 
after reconstitution, 8 chimeric mice were analyzed for each group. (A) FACS profiles were 
gated on CD45.1+ donor cells. Gates show B220+ CD19+ B cells, NK1.1+ CD122+ NK cells, and 
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CD4+ and CD8+ T cells. Numbers are percentages. (B) Absolute cell number of B, NK, CD4 and 
CD8 T cells in spleen of RAG2-/- γc-/- and RAG2-/- γc-/- K14-TSLP Tg recipients. Histograms 
represent the mean and standard deviation. (C) Quantification of LN present in RAG2-/- γc-/- and 
RAG2-/- γc-/- K14-TSLP Tg recipients. 
 
Material and methods 
 
Mice  
All mice were bred and maintained in our animal facility under specific pathogen-free 
conditions. The animal experiments received the approval of the Cantonal Veterinary Office of 
the city of Basel, Switzerland. C57BL/6 mice were purchased from RCC, Itingen, Switzerland. 
IL-7-/- [7], LTα-/- [62], RORγ-/- [80], TSLPR-/- [141] and K14-TSLP Tg [160] mice were 
previously described. RAG2-/- gc-/- mice on C57BL/6 background were kindly provided by Jörg 
Kirberg, MPI Freiburg, Germany.  
For FL chimera, IL-7-/- K14-TSLP Tg mice, IL-7-/- littermates and C57BL/6 WT mice 
were lethally γ-irradiated (9 Gy) and i.v. injected with 106 total FL cells from 12.5 embryos 
(CD45.1+). 10 days after reconstitution, FL chimera were analyzed for LTi presence. For BM 
chimera, RAG2-/- gc-/- K14-TSLP Tg mice and RAG2-/- gc-/- mice littermates were sub-lethally γ-
irradiated (5 Gy) and i.v. injected with 106 total BM cells together with 105 FACS sorted CD4+ 
CD25+ regulatory T cells from CD45.1+ animals. 4 weeks after reconstitution, BM chimeric 
mice were injected with Chicago Blue ink and analyzed. 
 
Flow cytometry and cell sorting 
FITC, PE, PE-Cy7, APC or biotin-conjugated α-CD4 (GK1.5), α-CD8α (53-6.7), α-CD19 
(1D3), α-NK1.1 (PK 136), α-α4β7 (DATK32), α-ICAM-1(3E2) and α-phospho-STAT5 (47) 
Abs were purchased from BD Biosciences. α-CD3 (145-2C11), α-B220 (RA3-6B2) Abs were 
purchased from Biolegend. α-CD45 (30-F11), α-CD117 (2B8), α-CD122 (TM-b1), α-IL-7Rα 
(A7R34) and α-VCAM-1 (429) Abs were purchased from e-Bioscience (San Diego, CA). As 
secondary reagent, Streptavidin-PE and Streptavidin-PE/Cy7 (Biolegend) were used. Flow 
cytometry acquisition was performed with a FACSCaliburTM (BD Biosciences) and data were 
analyzed using Flowjo software (Tree star). α-TSLPR Ab (AF546) was purchased from R&D 
systems (Minneapolis). 
Erythrocyte-depleted 14.5 dpc FL LTi-progenitors were sorted as lineage (CD3, CD11c, CD19, 
Ter119, Gr-1, B220, NK1.1)- α4β7+ CD117+ cells. Cell sorting was done using a FACS AriaTM 
(BD Biosciences) and re-analysis of sorted cells indicated that they were >98% pure.  
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For LTi cell number quantification, mLN and spleen from individual 0.5 day old mice 
were homogenized, filtered and stained. The entire organs were acquired on FACSCaliburTM and 
CD4+ CD3- CD127+ LTi absolute cell numbers were obtained from analysis. 
For assaying STAT5 phosphorylation, lineage- α4β7+ CD117+ FL cells were FACS-sorted. 
Alternatively, newborn mLN and adult spleen were homogenized and filtered. Sorted and non-
sorted cells were allowed to rest for 2 hours with complete IMDM in round bottom 96-well plate 
(Falcon). Cells were then stimulated 10 minutes with 100ng/ml of either recombinant TSLP 
(R&D) or IL-7 (PerproTech) and fixed for 10 minutes with 2% paraformaldehyde (AppliChem) 
at room temperature. Cells from mLN and spleen were stained for surface epitope for CD45, 
CD3 and CD4. Permeabilization was done with 90% methanol on ice for 30 min and phospho-
STAT5 staining was performed at room temperature for 30 min.  
For organizer cells staining, iLN of 2.5 days old mice were digested with 1mg/ml dispase 
(GIBCO) together with 100µg/ml DNase I (AppliChem) in PBS at 37°C for 20-30 minutes under 
mild agitation. Cell suspension was then filtered and stained on ice. 
 
Detection of LN 
LN enumeration was done a week after peritoneal injection of 100µl of 1% Chicago sky 
Blue 6B (Sigma) ink in PBS. LN Images were captured with stereoscopic Nikon SMZ1500 
microscope coupled with a DS Camera control Unit DS-L1 (Nikon). 
 
Immunofluorescence microscopy 
8µm acetone-fixed LN sections were incubated with combinations of ER-TR7 (ER-TR7, 
AbD Serotec), PNAd (MECA-79, Pharmingen), Lyve-1 (RELIATech), CXCL13 (R&D), CCL19 
(R&D), biot-CR1 (Pharmingen) and biot-CD31 (390, e-Biosciences) Abs. ER-TR7 and PNAd 
were detected with goat α-rat-Cy3 (Jackson ImmunoResearch), CXCL13 and CCL19 with a 
donkey α-goat Alexa 488 (Molecular probes), Lyve-1 with a goat α-rabbit Alexa 488 (Molecular 
probes) and CR1 and CD31 with Streptavidin-Alexa-488 (Molecular Probes).  
Images were captured on a Zeiss LSM 510 Meta Laser Confocal Scanning Confocal 
Microscope System (Carl-Zeiss, Fedbach, Switzerland). When required, images were assembled 
using Adobe Illustrator CS or Adobe Photoshop CS.  
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E. General discussion 
 
IL-7 and TSLP have partially overlapping activity 
TSLP is able to sustain B and T cell development in vitro [105, 106, 121, 132, 146, 148, 
150, 160] and to promote B and T lymphopoiesis in vivo [106, 120, 133, 141, 160]. In line with 
this, we have shown that TSLP can substitute IL-7 for developing and peripheral lymphocyte 
compartments in vivo [160]. We extended this observation to LN organogenesis by showing that 
TSLP can replace IL-7 for LN development and can increase the size of the LTi cell pool. 
Altogether these results demonstrate that TSLP and IL-7 have overlapping activities on 
lymphopoiesis, lymphocyte homeostasis, regulation of LTi cell number and LN development.  
TSLP does not share high homology with IL-7, nor TSLPR with γc [106, 123]. Hence, the 
IL-7Rα/STAT5 axis, which is shared by IL-7 and TSLP, might be the most prominent pathway 
explaining the redundancy of activity of these cytokines. Anti-apoptotic molecules of the Bcl-2 
family, such as Bcl-xL [166] and Mcl-1 [167] are known targets of this pathway. Overexpression 
of Bcl-2 Tg expression is able to restore the defect in T lymphopoiesis in IL-7Rα-/- mice [168, 
169]. It is therefore possible that TSLP restores T cell development by upregulating the 
expression of Bcl-2 family members.  
TSLP also displays activities, which are not shared with IL-7. For instance, TSLP 
promotes TH2 differentiation [109, 110, 144, 147, 151] and is perceived by the organism as a 
“danger” molecule. It is a potent activator of DC [108, 111, 112, 143-147], and is implicated in 
allergic diseases pathogenesis [110, 113, 118, 145, 147, 154]. Consistent with a role on myeloid 
cells, we and others have shown that TSLP Tg expression leads to the accumulation of erythroid 
precursors and granulocytes in the spleen [160, 170]. The understanding of TSLP signaling 
cascade might help to understand the mechanisms underlying TSLP specific biological activities.  
 
TSLP availability  
Several lines of evidences initially suggested that TSLP was promoting fetal rather than 
adult lymphopoiesis. Lymphopoiesis in newborn IL-7-/- mice is less severely impaired than in 
adults [5, 32]. The BM and spleen of young γc-/- animals contain more cells from the B cell 
lineage than IL-7Rα-/- controls [136] and fetal pro-B cells proliferate in response to TSLP in 
vitro whereas adult progenitors do not [136, 137]. Hence, it has been proposed that fetal but not 
adult cells were TSLP responsive [136, 137]. 
In contrast, our results indicate that adult hematopoietic cells are responsive to TSLP. 
Adult WT BM precursors proliferated and differentiated towards the B and T lineages in 
response to TSLP in vitro. BM chimera experiments showed that TSLP could sustain B and T 
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cell development from WT adult precursors [160]. The DNA of B cells from IL-7-/- TSLP Tg 
mice displayed N nucleotides at the rearranged Ig HC locus, suggesting that they were derived 
from adult precursors [160]. Hence our results rather indicate that TSLP does not play a 
significant role in adult lymphopoiesis because its availability might be too low.  
The analysis of TSLPR-/- or IL-7-/- TSLPR-/- mice later suggested that endogenous levels of 
TSLP do not play a substantial role in fetal and adult lymphopoiesis [134, 135, 139, 141, 149] 
nor in LN organogenesis (our unpublished data). Hence, it stems from these results that 
endogenous TSLP does not contribute to lymphopoiesis and LN organogenesis because TSLP 
constitutive levels might be too low in lymphoid microenvironments. The promoter of TSLP 
contains two NF-κB sites [116] and TSLP expression is upregulated under pro-inflammatory 
conditions [114-117]. Hence, an intriguing possibility is that TSLP might promote 
lymphopoiesis, lymphoid homeostasis or lymphoid tissue neogenesis under circumstances of 
stress, physical injuries, microbial or viral infections or inflammation.  
 
Role of peripheral lymphocytes in LN organogenesis 
LN are normally found in lymphopenic mice such as severe combined immunodeficient 
(SCID), RAG1-/- and RAG2-/- mice, showing that peripheral T and B cells are dispensable for LN 
formation and maintenance. It was possible that, in these mice, LN persisted through an effect of 
NK cells. However, this possibility was unlikely because the NK compartment, which is normal 
in IL-7-/- mice [171], is not sufficient to maintain the LN anlage. We show here that peripheral B, 
T and NK cells are not required for murine LN organogenesis. These results are of importance 
because they show that lymphopoiesis and the development of LN are independent processes. 
By injecting high numbers of adult lymphocytes the first week of life, it was recently 
shown that LN development could be restored in RAG2-/- γc-/- mice [161]. These results 
suggested that in postnatal life, peripheral lymphocytes might play a role in maintaining the LN 
anlage [161]. In view of our results, we believe that this lymphocyte-mediated LN restoration 
rather illustrates the capacity for adult lymphocytes to trigger LN organogenesis under certain 
conditions. In this line, B and CD4+ T cells were shown to be instrumental for the development 
of lymphoid tissues within the pancreas and the thyroid of mice overexpressing chemokines in 
these organs [172, 173]. 
While showing that lymphocytes are not required for LN formation, our results show that 
lymphocyte presence is instrumental for the full maturation of the LN architecture and for the 
development of certain stromal populations, such as FDC. Whether, reconstitution with WT BM 
is sufficient to restore LN architecture, FDC networks and to normalize HEV localization in LN 
of RAG2-/- γc-/- TSLP Tg mice, has still to be addressed.  
 
66
  
Importance of LTi cell number in LN organogenesis 
IL-7 availability regulates the size of the pool of LTi cells [92]. IL-7 overexpression 
increases LTi cell number and leads to the LTi-dependent formation of ectopic LN [92] whereas 
IL-7 deficiency leads to defective LN development [92, 160]. Altogether, these results suggest 
that IL-7 availability controls LN organogenesis by regulating LTi cell number. 
In this line, our results show that TSLP Tg expression rescues LN organogenesis in IL-7-/- 
and RAG2-/- γc-/- mice and suggest that insufficient LTi cell number is the primary cause for the 
defective LN development in both strains. The number of LTi cells required for successfully 
inducing LN formation remains to be determined and is likely to be different for each type of 
LN. Our results indicate that the cellular requirement for LN formation is limited to LTi and 
organizer cells, the two populations initially identified as initiating LN organogenesis [87]. 
However, they do not formally exclude the possibility that other cell types, as in PP 
organogenesis [174], play a role.  
Human patients with γc and JAK3 deficiency lack LN [175]. While the cellular and 
molecular players involved in human LN development are not yet identified [176], it is likely 
that LN organogenesis occurs according a similar scheme as in the murine system. Hence, our 
data might help understanding the defective LN formation observed in γc and JAK3-deficient 
patients.  
 
Cross-talk between lymphoid and stroma cells 
Our results show that IL-7-/- mice have thymic epithelial cells with an immature phenotype, 
and that the TSLP Tg expression, likely by restoring T cell development, normalizes thymic 
architecture [160]. LTi cells were recently shown to promote the maturation of mTEC during 
fetal life [177]. Hence, thymic microenvironment appears to be shaped by the interaction 
between lymphoid and mesenchymal cells. Our results also suggest that the LTi cell number has 
a direct impact on the mesenchymal organizer cells in the LN anlage. They further show that the 
LN architecture and the localization of HEV are affected by lymphocytes. Consistently, vascular 
architecture is remodeled upon lymphocyte colonization of the PP anlage [178]. Our data show 
that the development of mesenchymal FDC compartment in the LN are dependent on 
lymphocytes. Hence, altogether, our results illustrate the importance of the interaction between 
cells of the hematopoietic and non-hematopoietic lineages for the normal development of the 
immune system. 
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